deoxycytidine and Colonic Neoplasms

deoxycytidine has been researched along with Colonic Neoplasms in 299 studies

Research

Studies (299)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (0.67)	18.7374
1990's	24 (8.03)	18.2507
2000's	116 (38.80)	29.6817
2010's	152 (50.84)	24.3611
2020's	5 (1.67)	2.80

Authors

Authors	Studies
Begg, W; Kibudde, S	1
Dahabreh, IJ; García-Albéniz, X; Hernán, MA; Howlader, N; Logan, RW; Mariotto, AB; Petito, LC	1
Aasbrenn, M; Abd El-Aty, AM; Abdu, A; Abraha, HB; Achour, A; Acquaroni, M; Addeo, P; Agback, P; Agback, T; Al-Alwan, M; Al-Mazrou, A; Al-Mohanna, F; Aliste, M; Almquist, J; Andel, J; Ando, M; Angelov, A; Annuar, MSM; Antwi, K; Arroliga, AC; Arruda, SLM; Asch, SM; Averous, G; Ayaz, S; Ayer, GB; Bachellier, P; Ball, S; Banijamali, AR; Barden, TC; Bartoncini, S; Bedanie, G; Bellò, M; Benić, F; Berhe, GG; Bertiger, G; Beumer, JH; Bhandari, B; Bond, DS; Boules, M; Braüner Christensen, J; Brown-Johnson, C; Burgstaller, S; Cao, L; Capasso, C; Carlevato, R; Carvalho, AE; Ceci, F; Chagas, ATA; Chavan, SG; Chen, AP; Chen, HC; Chen, J; Chen, Q; Chen, Y; Chen, YF; Christ, ER; Chu, CW; Covey, JM; Coyne, GO'; Cristea, MC; Currie, MG; Dahdal, DN; Dai, L; Dang, Z; de Abreu, NL; de Carvalho, KMB; de la Plaza Llamas, R; Deandreis, D; Del Prete, S; Dennis, JA; Deur, J; Díaz Candelas, DA; Divyapriya, G; Djanani, A; Dodig, D; Doki, Y; Doroshow, JH; Dos Santos, RC; Durairaj, N; Dutra, ES; Eguchi, H; Eisterer, W; Ekmann, A; Elakkad, A; Evans, WE; Fan, W; Fang, Z; Faria, HP; Farris, SG; Fenoll, J; Fernandez-Botran, R; Flores, P; Fujita, J; Gan, L; Gandara, DR; Gao, X; Garcia, AA; Garrido, I; Gebru, HA; Gerger, A; Germano, P; Ghamande, S; Ghebeh, H; Giver Jensen, T; Go, A; Goichot, B; Goldwater, M; Gontero, P; Greil, R; Gruenberger, B; Guarneri, A; Guo, Y; Gupta, S; Haxholdt Lunn, T; Hayek, AJ; He, ML; Hellín, P; Hepprich, M; Hernández de Rodas, E; Hill, A; Hndeya, AG; Holdsworth, LM; Hookey, L; Howie, W; Hu, G; Huang, JD; Huang, SY; Hubmann, E; Hwang, SY; Imamura, H; Imperiale, A; Jiang, JQ; Jimenez, JL; Jin, F; Jin, H; Johnson, KL; Joseph, A; Juwara, L; Kalapothakis, E; Karami, H; Karayağiz Muslu, G; Kawabata, R; Kerwin, J; Khan, I; Khin, S; Kidanemariam, HG; Kinders, RJ; Klepov, VV; Koehler, S; Korger, M; Kovačić, S; Koyappayil, A; Kroll, MH; Kuban, J; Kummar, S; Kung, HF; Kurokawa, Y; Laengle, F; Lan, J; Leal, HG; Lee, MH; Lemos, KGE; Li, B; Li, G; Li, H; Li, X; Li, Y; Li, Z; Liebl, W; Lillaz, B; Lin, F; Lin, L; Lin, MCM; Lin, Y; Lin, YP; Lipton, RB; Liu, J; Liu, W; Liu, Z; Lu, J; Lu, LY; Lu, YJ; Ludwig, S; Luo, Y; Ma, L; Ma, W; Machado-Coelho, GLL; Mahmoodi, B; Mahoney, M; Mahvash, A; Mansour, FA; Mao, X; Marinho, CC; Masferrer, JL; Matana Kaštelan, Z; Melendez-Araújo, MS; Méndez-Chacón, E; Miletić, D; Miller, B; Miller, E; Miller, SB; Mo, L; Moazzen, M; Mohammadniaei, M; Montaz-Rosset, MS; Mousavi Khaneghah, A; Mühlethaler, K; Mukhopadhyay, S; Mulugeta, A; Nambi, IM; Navarro, S; Nazmara, S; Neumann, HJ; Newman, EM; Nguyen, HTT; Nicolato, AJPG; Nicolotti, DG; Nieva, JJ; Nilvebrant, J; Nocentini, A; Nugent, K; Nunez-Rodriguez, DL; Nygren, PÅ; Oberli, A; Oderda, M; Odisio, B; Oehler, L; Otludil, B; Overman, M; Özdemir, M; Pace, KA; Palm, H; Parchment, RE; Parise, R; Passera, R; Pavlovic, J; Pecherstorfer, M; Peng, Z; Pérez Coll, C; Petzer, A; Philipp-Abbrederis, K; Pichler, P; Piekarz, RL; Pilati, E; Pimentel, JDSM; Posch, F; Prager, G; Pressel, E; Profy, AT; Qi, P; Qi, Y; Qiu, C; Rajasekhar, B; Ramia, JM; Raynor, HA; Reis, VW; Reubi, JC; Ricardi, U; Riedl, JM; Romano, F; Rong, X; Rubinstein, L; Rumboldt, Z; Sabir, S; Safaeinili, N; Sala, BM; Sandoval Castillo, L; Sau, M; Sbhatu, DB; Schulte, T; Scott, V; Shan, H; Shao, Y; Shariatifar, N; Shaw, JG; She, Y; Shen, B; Shernyukov, A; Sheth, RA; Shi, B; Shi, R; Shum, KT; Silva, JC; Singh, A; Sinha, N; Sirajudeen, AAO; Slaven, J; Sliwa, T; Somme, F; Song, S; Steinberg, SM; Subramaniam, R; Suetta, C; Sui, Y; Sun, B; Sun, C; Sun, H; Sun, Y; Supuran, CT; Surger, M; Svartz, G; Takahashi, T; Takeno, A; Tam, AL; Tang, Z; Tanner, JA; Tannich, E; Taye, MG; Tekle, HT; Thomas, GJ; Tian, Y; Tobin, JV; Todd Milne, G; Tong, X; Une, C; Vela, N; Venkateshwaran, U; Villagrán de Tercero, CI; Wakefield, JD; Wampfler, R; Wan, M; Wang, C; Wang, J; Wang, L; Wang, S; Waser, B; Watt, RM; Wei, B; Wei, L; Weldemichael, MY; Wellmann, IA; Wen, A; Wild, D; Wilthoner, K; Winder, T; Wing, RR; Winget, M; Wöll, E; Wong, KL; Wong, KT; Wu, D; Wu, Q; Wu, Y; Xiang, T; Xiang, Z; Xu, F; Xu, L; Yamasaki, M; Yamashita, K; Yan, H; Yan, Y; Yang, C; Yang, H; Yang, J; Yang, N; Yang, Y; Yau, P; Yu, M; Yuan, Q; Zhan, S; Zhang, B; Zhang, H; Zhang, J; Zhang, N; Zhang, Y; Zhao, X; Zheng, BJ; Zheng, H; Zheng, W; Zhou, H; Zhou, X; Zhu, S; Zimmer, DP; Zionts, D; Zitella, A; Zlott, J; Zolfaghari, K; Zuo, D; Zur Loye, HC; Žuža, I	1
Angelis De, V; Chovanec, M; Hlavčák, P; Janega, P; Jurišová, S; Macák, D; Makovník, M; Mardiak, J; Mego, M; Pinďák, D; Rejleková, K	1
Cepero, A; Martin-Guerrero, SM; Martin-Oliva, D; Melguizo, C; Munoz-Gamez, JA; Ortiz, R; Prados, J; Quinonero, F; Urbano, D	1
Chen, X; Gao, G; Guo, Y; Liang, G; Liu, J; Wang, D; Wu, FG; Wu, Y; Zhang, X; Zhao, Y	1
Abe, T; Furuhashi, T; Fuyuno, S; Hatada, T; Sato, N	1
Avraham, R; Barshack, I; Barzily-Rokni, M; Bhatia, SN; Brandis, A; Bu, J; Chatman, K; Cooper, ZA; Danino, T; Ferrone, CR; Flaherty, KT; Fleming, J; Frederick, DT; Fuks, G; Garrett, WS; Gavert, N; Geller, LT; Gevers, D; Golan, T; Golub, TR; Gopalakrishnan, V; Gurbatri, C; Hurd, MW; Huttenhower, C; Johnston, SE; Jonas, OH; Katz, M; Kim, M; Ligorio, M; Livny, J; Maitra, A; Mandinova, A; Michaud, M; Mosher, CM; Nejman, D; Reuben, A; Sandbank, J; Shee, K; Shental, N; Skalak, M; Smith, DA; Straussman, R; Thaiss, CA; Thayer, SP; Trauger, SA; Wargo, JA; Zwang, Y	1
Nunes, AA; Pereira, LRL; Peria, FM; Ungari, AQ	1
Fukuda, M; Hosokawa, M; Iwakawa, S; Masuda, A; Tanaka, S; Ueda, K	1
Kagawa, Y; Kato, T; Katsura, Y; Kawai, K; Murakami, K; Murata, K; Naito, A; Nakatsuka, S; Nose, Y; Omura, Y; Sakamoto, T; Takase, K; Takeda, Y; Takeno, A; Tamura, S	1
Ishibashi, K; Ishida, H; Kato, H; Kato, R; Koda, K; Kosugi, C; Mori, M; Narushima, K; Oya, M; Shuto, K; Tanaka, S; Yoshimatsu, K	1
Baretti, M; Bozzarelli, S; Giordano, L; Personeni, N; Pressiani, T; Rimassa, L; Santoro, A; Tronconi, MC	1
Albrecht, MH; Gruber-Rouh, T; Hammerstingl, R; Lahrsow, M; Thompson, ZM; Vogl, TJ	1
Arafat, K; Attoub, S; Iratni, R; Khalaf, T; Sulaiman, S	1
Gelderblom, HJ; Mancao, C; Mesker, WE; Putter, H; Tollenaar, RA; van Pelt, GW; Zunder, SM	1
Banaszkiewicz, Z; Bodnar, M; Dziaman, T; Foksinski, M; Gackowski, D; Gawronski, M; Guz, J; Klopocka, M; Labejszo, A; Liebert, A; Linowiecka, K; Marszalek, A; Modrzejewska, M; Olinski, R; Starczak, M; Szpila, A; Szpotan, J; Zarakowska, E	1
Chu, E; Lee, JJ	1
Esna-Ashari, O; Fathi-Azarbayjani, A; Kheradmand, F; Malekinejad, H; Mohammadian, M; Rasmi, Y; Zeynali-Moghaddam, S	1
Jain, A; Jain, AK; Prajapati, SK; Shrivastava, C	1
Taieb, J; Zaanan, A	1
Ali, M; Batool, F; Fatima, M; Iqbal Ahmed, MM; Munch-Petersen, B; Mutahir, Z; Riaz, A	1
Ciardiello, D; Ciardiello, F; Conzo, G; Coppola, N; De Falco, V; De Vita, F; Giunta, EF; Marinaccio, A; Martinelli, E; Napolitano, S; Natalicchio, MI; Troiani, T; Vietri, MT; Vitale, P; Vitiello, PP; Zanaletti, N	1
Deng, HX; Li, Q; Wei, YQ; Wen, F; Xie, Q	1
Deguchi, T; Fukui, A; Iwase, K; Kawata, J; Matsuda, C; Nezu, R; Nishikawa, K; Takagi, M; Tamagawa, H; Tanaka, Y	1
Benson, AB	1
Albini, A; Banzi, M; Boni, C; Casali, B; Farnetti, E; Focaccetti, C; Magnani, E; Nicoli, D; Savoldi, L	1
Choi, MH; Kim, JS; Lim, SK; Shin, DH	1
Boulware, SB; Christensen, LA; Coghlan, L; Finch, RA; Thames, H; Vasquez, KM	1
Li, R; Li, W; Shi, L; Shuai, X; Tao, K; Wang, G; Wu, K; Yin, Y; Zhang, P; Zhao, E	1
Hashimoto, T; Kimura, S; Toyono, M; Usuba, O; Yokoyama, M	1
Fujiyama, Y; Kaneko, H; Kikuchi, M; Kinoshita, S; Nishizawa, T; Sakuno, T; Suzuki, H; Takahashi, M	1
Aglietta, M; Artale, S; Cagnazzo, C; Capussotti, L; Cascinu, S; De Carlis, L; Di Fabio, F; Fornarini, G; Gioeni, L; Leone, F; Marino, D; Pinto, C; Pugliese, R; Sartore-Bianchi, A; Siena, S; Tampellini, M	1
Clements, D; Giacomantonio, CA; Gujar, SA; Hill, R; Lee, PW; Madureira, PA; Rabb, M; Waisman, DM	1
Badzek, S; Bilic, E; Golem, H; Gorsic, I; Kekez, D; Librenjak, N; Miletic, V; Plestina, S; Prejac, J	1
Arnold, D; Beretta, GD; Cervantes, A; Labianca, R; Mandalà, M; Mosconi, S; Nordlinger, B	1
Brons, S; Combs, SE; Debus, J; Haberer, T; Schlaich, F; Weber, KJ	1
Hasegawa, H; Kubo, H; Miyahara, M; Nakasuga, C; Tada, K	1
Ikeda, H; Kato, H; Kodera, M; Mizuno, K; Oishi, M; Seshimo, K; Toshima, T; Yamamura, M; Yamashita, Y	1
Bank, PC; Guchelaar, HJ; Swen, JJ	1
Chen, Y; Cui, YH; Guo, X; Liu, TS; Yu, YY; Zhou, YH; Zhuang, RY	1
Asaka, S; Katsube, T; Kohno, T; Miyaki, A; Miyazawa, M; Murayama, M; Naritaka, Y; Shimakawa, T; Shimazaki, A; Shiozawa, S; Usuda, A; Yamaguchi, K; Yokomizo, H; Yoshimatsu, K	1
Ghosh, S; Loree, JM; Mulder, KE; Spratlin, JL	2
Koshida, Y; Mukai, K; Nishi, T; Shimoyama, Y; Toriumi, F; Yamamoto, T; Yamanashi, T	1
Guo, XD; Hu, DL; Sun, ZN; Zhao, YM	1
Alami, M; Boissenot, T; Brion, JD; Couvreur, P; Desmaële, D; Hamze, A; Maksimenko, A; Mougin, J; Provot, O; Pruvost, A; Zouhiri, F	1
de Haes, JH; Henselmans, I; van Laarhoven, HW	1
Cai, Q; Chen, X; Ji, J; Jiang, J; Liu, B; Shi, H; Shi, M; Yu, Y; Zhang, J; Zhu, Z	1
Gervasi, E; Giovanardi, F; Pezzuolo, D; Prati, G; Scaltriti, L; Scarabelli, L	1
Hara, K; Ishii, T; Kondo, H; Koyama, I; Morita, Y; Suzuki, A; Tashiro, J; Yamaguchi, S	1
Du, QG; Guo, XY; Han, S; Hao, ZM; Liu, GS; Lv, YF; Wang, P; Zhu, SM	1
Hirano, S; Kuroda, A; Kuwatani, T; Kyogoku, N; Maki, T; Miyauchi, K; Shichinohe, T; Takeuchi, S; Tsuchikawa, T; Wada, M; Yamamura, Y	1
Bekaii-Saab, T; Benson, AB; Chan, E; Chen, YJ; Cooper, HS; Engstrom, PF; Enzinger, PC; Fenton, MJ; Freedman-Cass, DA; Fuchs, CS; Gregory, KM; Grem, JL; Hunt, S; Kamel, A; Leong, LA; Lin, E; Messersmith, W; Mulcahy, MF; Murphy, JD; Nurkin, S; Rohren, E; Ryan, DP; Saltz, L; Sharma, S; Shibata, D; Skibber, JM; Sofocleous, CT; Stoffel, EM; Stotsky-Himelfarb, E; Venook, AP; Willett, CG	1
Galsky, MD; Gimpel-Tetra, K; Godbold, J; Holcombe, RF; Lee, KM; Lowe, N; Misiukiewicz, K; Oh, WK; Posner, M; Soto, R; Tsao, CK	1
Battisti, S; Guida, FM; Pagliara, E; Santini, D; Tonini, G; Zobel, BB	1
Armstrong, DE; Ghosh, S; Kim, CA; Mulder, KE; Spratlin, JL	1
Ahn, JB; Bello, M; Charoentum, C; Chen, LT; Cheng, AL; Ciardiello, F; de Lima Lopes, G; Ho, GF; Kim, TW; Köhne, CH; Kong, HL; Lam, KO; Li, J; Liu, TS; Ma, BB; Park, YS; Shaw, M; Sriuranpong, V; Sudoyo, AW; Teh, C; Vaid, AK; Wang, JY; Zhang, J; Zhang, SZ	1
Cleator, S; Dzaye, O; Nihoyannopoulos, P	1
Kawara, H; Mitani, T; Noguchi, Y; Shimizu, Y; Tokuyama, Y; Tsurushima, M; Uchiyama, K	1
Chiche, L; Dicostanzo, MP; Fongue, J; Harlé, JR; Lardet, D; Meunier, B; Richard, MA; Rouby, F; Terrier, JP	1
Ban, T; Ikegaya, Y; Isogai, N; Kawachi, J; Miyake, K; Ogino, H; Shimoyama, R; Watanabe, K	1
Faez, L; Garrido, M; Jiménez-Fonseca, P; Menendez, MD; Rodriguez, D; Ruiz, AL; Sanchez Lorenzo, ML; Solis, MP; Uriol, E; Viéitez, JM	1
Cartwright, T; Haller, D; Lee, S; McKenna, E; O'Connell, MJ; Saif, M; Schmoll, HJ; Sun, W; Twelves, C; Yothers, G	1
Du, ZD; He, XF; Li, Q; Tang, RL; Wen, F; Yao, K; Zhang, PF	1
Aksoy, A; Arpaci, E; Bahceci, A; Bayoglu, IV; Besiroglu, M; Dane, F; Duran, AO; Hacibekiroglu, I; Inanc, M; Karaca, H; Menekse, S; Ozkan, M; Sevinc, A; Tanriverdi, O; Uysal, M; Yapici, HS; Yazilitas, D	1
Fennig, S; Greenberg, G; Leshem, Y; Talianski, E; Wolf, I	1
Desurmont, T; Duchene, B; Duhamel, A; Gosset, P; Hebbar, M; Huet, G; Jonckheere, N; Leteurtre, E; Millet, G; Pruvot, FR; Ramdane, N; Skrypek, N; Truant, S; Van Seuningen, I	1
Kakizawa, N; Kato, T; Noda, H; Rikiyama, T; Toyama, N; Watanabe, F	1
Guggenberger, D; Hansen, R; Jacobs, G; Kröning, H; Schardt, C; Schmidt, P; Steffens, CC; Tschechne, B; Valdix, AR; Wohlfarth, T	1
Hosaka, S; Kawamoto, S; Maeno, H; Ohara, C; Okubo, S; Umemoto, S; Yonemitsu, K; Yoshida, T	1
Ishizu, H; Kuji, M; Masuko, H; Matsumoto, S; Takahashi, M; Takahashi, S; Tanioka, T; Yamagami, H	1
Hanyu, T; Hashimoto, Y; Hosoi, M; Ishikawa, T; Kameyama, H; Kobayashi, T; Kosugi, S; Koyama, Y; Minagawa, M; Nakano, M; Nogami, H; Sakata, J; Shimada, Y; Takizawa, K; Wakai, T	1
Doi, S; Kan, K; Maruyama, H; Murata, K; Nakaguchi, K; Nakano, K; Nushijima, Y; Okamura, S; Sugimoto, K	1
Hanyu, T; Ichikawa, H; Ishikawa, T; Kameyama, H; Kobayashi, T; Kosugi, S; Koyama, Y; Minagawa, M; Nakano, M; Sakata, J; Shimada, Y; Tanaka, R; Wakai, T	1
Ishii, K; Kanamoto, A; Miyanaga, S; Noto, M; Takeda, T; Tani, T; Yagi, M	1
Choi, MG; Jeong, D; Min, D; Na, K	1
Dai, Y; Ishibashi, O; Kondo, T; Maeda, M; Ohkohchi, N; Watanabe, M	1
de Braud, F; Haller, DG; Hill, M; Hoersch, S; Maroun, J; Price, T; Rittweger, K; Schmoll, HJ; Tabernero, J; Van Cutsem, E	1
Byrne, WL; Cummins, J; Lehouritis, P; McCarthy, FO; Murphy, CT; Reid, G; Stanton, M; Tangney, M; Urbaniak, C	1
Hayakawa, M; Koketsu, H; Matsuda, S; Nagata, N	1
Barda, D; Barnard, D; Beckmann, R; Burke, T; Diaz, HB; Donoho, G; Jones, B; King, C; Marshall, M	1
Cai, S; Hu, J; Xu, Y	1
Jiang, Y; Lin, Z; Liu, G; Ren, N; Shi, Y; Xu, W	1
Achrekar, MS; Carvalho, MD; D'souza, A; Govindarajan, S; Gupta, S; Murugan, K; Ostwal, V	1
André, T; Aparicio, T; Bedenne, L; Carola, E; Cristol-Dalstein, L; Faroux, R; Francois, E; Maillard, E; Paillaud, E; Retornaz, F; Seitz, JF	1
Sugihara, K; Tsuji, Y	1
Kinoshita, A; Koike, K; Koyama, M; Nishino, H; Tanaka, K	1
Creemers, GJ; Janssen-Heijnen, ML; Lemmens, VE; Maas, HA; Pruijt, JF; Razenberg, LG; van Erning, FN	1
Baidoo, KE; Brechbiel, MW; Milenic, DE; Yong, KJ	1
Aprile, G; Banzi, M; Barni, S; Cantore, M; Ciuffreda, L; Di Bartolomeo, M; Ferrari, D; Labianca, R; Lonardi, S; Maiello, E; Marchetti, P; Massida, B; Pasini, F; Rimassa, L; Ronzoni, M; Rosati, G; Rulli, E; Scartozzi, M; Sobrero, A; Zagonel, V; Zampino, MG; Zaniboni, A	1
Cao, YQ; Jing, K; Liang, TJ; Ma, MZ; Wang, XJ; Zhou, ZM	1
Fujii, T; Funahashi, K; Kaneko, H; Kaneko, T; Katayanagi, T; Koda, T; Koike, J; Kurihara, A; Masuhara, H; Sawaguchi, Y; Shimada, H; Shiokawa, H; Suzuki, T; Ushigome, M; Watanabe, Y	1
Komatu, T; Nomura, S; Ogasawara, T; Sato, Y; Shida, T; Takahara, Y; Takahashi, M; Uno, H	1
Hashimoto, Y; Hotta, S; Iwaki, T; Kameyama, H; Kobayashi, T; Oyamatsu, M; Sakata, J; Sato, K; Sato, Y; Shimada, Y; Wakai, T	1
Correale, P; Cusi, MG; Del Vecchio, MT; Fioravanti, A; Francini, E; Francini, G; Ginanneschi, C; Martellucci, I; Montagnani, F; Remondo, C; Rotundo, MS; Tagliaferri, P; Tassone, P	1
Duhoux, F; Mano, MS	1
Cheng, RC; Diao, C; Liu, QY; Su, YJ; Wei, XP; Xu, JB; Zhang, JM	1
Barberis, G; Cannone, M; Comella, P; Condemi, G; Farris, A; Filippelli, G; Maiorino, L; Massidda, B; Natale, D; Palmeri, S	1
Amadori, D; Antonuzzo, L; Barone, C; Bertetto, O; Carlo Merlano, M; Di Costanzo, F; Gasperoni, S; Labianca, R; Longo, F; Luppi, G; Mansueto, G; Ravasio, R; Sobrero, A; Vinante, O	1
Arnold, D; Bovenschulte, H; Coutelle, O; Fries, JW; Hacker, U; Stippel, D; Weihrauch, MR	1
Huh, JW; Jung, EJ; Kwon, JE; Lee, KY; Park, YA; Sohn, SK	1
Arnold, D	1
Gennatas, C; Gennatas, S; Michalaki, V	1
Gibson, OJ; Larsen, ME; Pearson, S; Rowntree, J; Smith, J; Tarassenko, L; Weaver, A; Young, AM	1
Ledbetter, L; Saif, MW; The, A	1
Akyürek, N; Benekli, M; Büyükberber, S; Coşkun, U; Demirci, U; Oztürk, B; Tonyali, O; Yildiz, R; Yilmaz, G	1
Murphy, KC	1
Easaw, JC; Vickers, MM	1
Bozkurt, MT; Cirak, Y; Degirmenci, M; Demir Piskin, G; Durusoy, R; Gorumlu, G; Karabulut, B; Karaca, B; Sanli, UA; Tunali, D; Uslu, R	1
Gunderson, HD; Leung, N; Shaikh, A; Wiisanen, ME	1
Achilli, F; Farina, A; Malafronte, C; Valsecchi, MA	1
Saltz, LB; Segal, NH	1
Ansaloni, L; Bazzoli, F; Cennamo, V; Ceroni, L; Eusebi, LH; Fuccio, L; Laterza, L; Martoni, AA; Minardi, ME; Mutri, V; Pinna, AD; Salfi, N	1
Fukuda, T; Ohashi, Y; Shimozuma, K; Shiroiwa, T; Tsutani, K	1
Quinn, B; Salvage, AV	1
Cho, YB; Chun, HK; Kim, HC; Lee, WY; Yun, HR; Yun, SH	1
Ding, PR; Li, LR; Lin, JZ; Pan, ZZ; Peng, ZH; Wan, DS; Wu, XJ; Zhou, ZG	1
An, X; Feng, F; He, YJ; Jiang, WQ; Li, YH; Wang, FH; Wang, ZQ; Xiang, XJ; Xu, RH	1
Kakar, M; Olsen, DR; Røe, K; Seierstad, T	1
Armesilla, AL; Brown, J; Darling, JL; Goessl, E; Guo, X; Pandey, S; Wang, W; Xu, B	1
Bao, J; Bender, DM; Dantzig, AH; Diseroad, WD; Law, KL; Magnus, NA; McCarthy, JR; Perkins, EJ; Peterson, JA; Pu, YJ; Remick, DM; Reutzel-Edens, SM; Starling, JJ; Stephenson, GA; Vaid, RK; Zhang, D	1
Atanassow, V; Braumann, C; Caldenas, S; Hartmann, J; Kilian, M; Makareinis, A; Raue, W; Schwenk, W	1
Dalgleish, AG; Fowler, DW; Liu, WM; Smith, P	1
Angus, E; Fincher, S; Garg, R	1
Lee, C; Saunders, M	1
Uña, E	1
Chun, HK; Lee, WS; Lee, WY; Son, HS; Yun, SH	1
Bae, SH; Chae, YS; Choi, GS; Jun, SH; Kang, BW; Kim, JG; Kim, NS; Moon, JH; Park, JH; Park, JY; Ryoo, HM; Sohn, SK	1
Arai, T; Hirai, H; Imagaki, K; Iwasawa, Y; Kobayashi, M; Kotani, H; Mizuarai, S; Nishibata, T; Ohtani, J; Okada, M; Sakai, N; Sakai, T; Yoshizumi, T	1
Cercueil, JP; Chauffert, B; Ghiringhelli, F; Guiu, B; Guiu, S; Ladoire, S; Ortega-Deballon, P; Vincent, J	1
Meirovitz, A; Sonnenblick, A	1
Correale, P; Del Vecchio, MT; Francini, G; Ginanneschi, C; Licchetta, A; Loiacono, L; Mannucci, S; Migali, C; Remondo, C; Rotundo, MS; Tagliaferri, P; Tassone, P; Tsang, KY	1
Abbruzzese, A; Arcuri, FP; Caraglia, M; Carducci, A; Correale, P; Del Vecchio, MT; Loiacono, L; Marra, M; Migali, C; Misso, G; Remondo, C; Tagliaferri, P; Tassone, P	1
Block, S	1
Arnold, D; Bruch, HP; Kirchner, T; Kubicka, S; Reinacher-Schick, A; Ridwelski, K; Schmoll, HJ; Trarbach, T	1
Adenis, A; Bennouna, J; Bergougnoux, L; Conroy, T; Douillard, JY; Ducreux, M; Faroux, R; Hebbar, M; Kockler, L; Lledo, G; Rebischung, C; Ychou, M	1
Banaszkiewicz, Z; Bartsch, H; Cadet, J; Chaber, A; Cieśla, JM; Douki, T; Gackowski, D; Janik, J; Janowska, B; Jawien, A; Kowalczyk, P; Krasnodebski, I; Nair, J; Obtułowicz, T; Olinski, R; Speina, E; Swoboda, M; Tudek, B; Winczura, A	1
Chauvin, F; Guastalla, JP; Jacquin, JP; Nourissat, A; Poirson, J; Regnier Denois, V	1
Xu, JM	1
Dalgleish, AG; Gravett, AM; Liu, WM	1
Aarntzen, EA; Adema, GJ; de Boer, A; de Vries, IJ; Figdor, CG; Lesterhuis, WJ; Preijers, FW; Punt, CJ; Scharenborg, NM; van de Rakt, M; van Spronsen, DJ	1
Alvarez, PJ; Aranega, A; Burgos, M; Hita, F; Melguizo, C; Ortiz, R; Prados, J; Rama, AR; Ramos, JL; Rodríguez-Serrano, F	1
Awada, A; Besse-Hammer, T; Brendel, E; Delesen, H; Gil, T; Hendlisz, A; Joosten, MC; Lathia, CD; Loembé, BA; Piccart-Ghebart, M; Van Hamme, J; Whenham, N	1
Zhang, SZ	1
Black, JM; Boh, EE; Farris, PK; Hodari, KT; Lewis, AT; Rogers, N	1
Czaykowski, P; Gordon, VL; Harding, GA	1
Azzariti, A; Bocci, G; Chiarappa, P; Del Bufalo, D; Del Tacca, M; Fioravanti, A; Mangia, A; Paradiso, A; Porcelli, L; Quatrale, AE; Sebastian, S; Simone, GM; Sini, P	1
Moon, S; Na, K; Yang, SG	1
de Braud, F; Gilberg, F; Haller, DG; Hill, M; Maroun, J; Price, T; Rittweger, K; Schmoll, HJ; Tabernero, J; Van Cutsem, E	1
Arima, N; Shigaki, N; Sugita, H; Suzuki, S; Yamashita, H; Yokoyama, S	1
Gilbar, P; Sorour, N	1
Benninger, K; Carson, WE; Chaudhury, AR; Guenterberg, K; Guttridge, DC; Jaime-Ramirez, AC; Khan, M; Kondadasula, SV; Kreiner, M; Kuppusamy, P; La Perle, KM; Lesinski, GB; Mundy-Bosse, BL; Young, G	1
Bang, SM; Chang, HJ; Kang, SB; Kim, DW; Kim, JH; Kim, YJ; Lee, JS; Lee, KW	1
Al-Niaimi, F; Lyon, C	1
Cassidy, J; Díaz-Rubio, E; Gilberg, F; McKendrick, J; Scheithauer, W; Seitz, JF; Twelves, C; Van Hazel, G; Wong, A	1
Goto, H; Hara, K; Higuchi, K; Hijioka, S; Kawai, H; Kondo, S; Mizuno, N; Nakamura, M; Niwa, Y; Ogura, T; Sawaki, A; Tajika, M; Yamao, K	1
Aparicio, J; Díaz-Rubio, E; Feliu, J; García-Carbonero, R; González-Flores, E; Grande, E; Pérez-Hoyos, T; Salud, A; Torres, E; Valero, M; Valladares-Ayerbes, M; Vieitez, JM	1
Koopman, M; Mol, L; Punt, CJ; Redekop, WK; Uyl-de Groot, CA; van Gils, CW	1
Baker, JH; Kyle, AH; Minchinton, AI	1
Akagi, Y; Ando, K; Emi, Y; Kakeji, Y; Kitazono, M; Maehara, Y; Morita, M; Natsugoe, S; Ogata, Y; Oki, E; Saeki, H; Sakaguchi, Y; Samura, H; Shirouzu, K; Sirzen, F; Tokunaga, S	1
Lee, JW; Na, K; Yang, SG	1
Agharbi, FZ; Benhemmne, H; Daoudi, K; Elmesbahi, O; Mernissi, FZ; Meziane, M; Mikou, O	1
Fukuda, M; Hanada, K; Hata, H; Ikai, I; Kubo, K; Moriyama, S; Murakami, T; Ogiso, S; Okazaki, S; Okuchi, Y; Otani, T; Sakata, S; Setoguchi, Y; Tanaka, M; Tani, M; Une, Y; Yamaguchi, T; Yamato, T; Yasui, H	1
Imai, E; Ito, I; Ito, Y; Kosugi, T; Maruyama, S; Matsuo, S; Mizuno, M; Ozaki, T; Sato, W; Suzuki, Y; Tsuboi, N; Yasuda, K; Yasuda, Y	1
Aracil, M; Arguelaguet, E; Hernández-Losa, J; Jimeno, J; Marés, R; Pons, B; Ramón Y Cajal, S; Somoza, R; Teixidó, C	1
Downward, J; Hancock, DC; Howell, M; Kelly, G; Kuznetsov, H; Marani, M; Molina-Arcas, M; Saunders, B; Steckel, M; Warne, PH; Weigelt, B	1
Li, W; Liu, H; Qu, X; Sun, C; Yue, B; Zhao, C	1
Cao, F; Han, N; He, K; Jin, K; Lan, H; Li, G; Teng, L; Xie, B; Xu, Z	1
Li, G; Li, W; Qu, X; Sun, C; Xue, X; Zhao, C	1
Dokmanovic, L; Janic, D; Krstovski, N; Lazic, J; Paripovic, L; Rodic, P	1
Bai, W; He, AR; Hwang, J; Marshall, J; Mikhail, S; Navarro, R; Pishvaian, M; Shivapurkar, N; Wellstein, A	1
Stiefelhagen, P	1
Conca, R; Correale, P; Fioravanti, A; Pastina, P; Tenti, S	1
Chachad, S; Malhotra, G; Naidu, R; Purandare, S	1
Benekli, M; Berk, V; Buyukberber, S; Cetin, B; Coskun, U; Isikdogan, A; Kaplan, MA; Ozkan, M; Tufan, G	1
André, T; Bajetta, E; Bodoky, G; Cartwright, TH; Clarke, S; Cunningham, D; de Gramont, A; Hecht, JR; Hoff, PM; Im, SA; Maindrault-Goebel, F; Makrutzki, M; Moore, MJ; Rivera, F; Salazar, R; Schmoll, HJ; Shacham-Shmueli, E; Shang, A; Tabernero, J; Van Cutsem, E	1
Schmutz, JL; Trechot, P	1
Chan, AO; Chan, HY; Ng, CM; Shek, CC; Tiu, SC	1
Chung, K; Hanada, S; Iwata, T; Kato, T; Miura, T; Nakata, K; Toda, M	1
Akiyoshi, T; Arita, J; Fujimoto, Y; Fukunaga, Y; Ikeda, A; Koga, R; Konishi, T; Mizunuma, N; Mukai, T; Nagasue, Y; Nagayama, S; Oikawa, Y; Saiura, A; Shinozaki, E; Suenaga, M; Ueno, M; Yamaguchi, T; Yamakawa, K; Yamamoto, C	1
Baba, H; Goseki, N; Kuwabara, H; Mitsuoka, A; Nakamura, H; Sanada, T; Watanabe, S; Yamamoto, Y	1
Amamori, K; Shigematsu, T; Shirai, M; Sunda, K; Takeda, K; Yamagiwa, K; Yamanda, T	1
Alexander, GC; de Souza, JA; Meropol, NJ; Newcomer, LN; Perkins, M; Polite, B; Ratain, MJ	1
Arredondo, J; Baixauli, J; Chopitea, A; González, I; Hernández-Lizoáin, JL; Pastor, C; Rodríguez, J; Vigil, C	1
Adjei, AA	1
Baay, MF; de Pooter, CM; Korst, AE; Lambrechts, HA; Lardon, F; Pattyn, GG; Pauwels, B; Vermorken, JB	1
Bernacki, RJ; Chaudhary, ND; Greco, W; Hoffman, RM; Kobayashi, T; Mazurchuk, R; Pera, P; Spernyak, J; Veith, J; Wu, M	1
Mayor, S	1
Brickell, K; Porter, D; Thompson, P	1
Auditore-Hargreaves, K; Axworthy, D; Dearstyne, E; Graves, SS; Gray, D; Jones, HM; Lin, Y; Pantalias, A; Sanderson, J; Schultz, J; Zuo, Y	1
Maeda, Y; Sasaki, E; Sasaki, T	1
Babarina, A; Kischkel, FC; Waldenmaier, DS	1
Begbie, S; Borner, M; Burns, WI; Burris, HA; Cassidy, J; Garcia-Alfonso, P; Jodrell, D; Koralewski, P; Levine, EL; Maroun, J; Marschner, N; McKendrick, J; Scheithauer, W; Tujakowski, J; Twelves, C; Van Hazel, G; Wong, A; Zaluski, J	1
Li, M; Rinehart, JJ; Wang, H; Zhang, R	1
Berger, MR; Leible, M; Sänger, J; Seelig, MH	1
Kondo, Y; Sato, A; Taguchi, T; Terashima, M	1
Adrian, TE; Ding, XZ; Hennig, R; Jovanovic, BD; Tong, WG; Witt, RC	1
Bajetta, E; Biasco, G; Brandi, G; Calabrese, C; Di Battista, M; Pantaleo, MA; Poggi, R	1
Adamer, F; Azria, D; Buchegger, F; Cottin, E; Coucke, PA; Decosterd, LA; Do, HP; Martineau, P	1
Grem, JL; Leonard, GD; Quinn, MG; Wagner, MR	1
Reddy, GK	1
Fujimura, T; Fushida, S; Miwa, K; Morita, A; Nagai, N; Ninomiya, I; Nishimura, G; Ohta, T; Takino, T; Terada, I; Yoshizumi, T	1
Grothey, A; Marsé, H; Valverde, S; Van Cutsem, E	1
Aksu, G; Fayda, M; Kapran, Y; Sakar, B	1
Cao, S; Durrani, FA; Rustum, YM	1
Bocci, G; Danesi, R; Di Paolo, A	1
Aksoy, S; Dinçer, M; Karaca, B; Yalçin, S	1
Vega-Stromberg, T	1
Di Costanzo, F; Doni, L	1
Abt, M; Burris, H; Carrato, A; Cassidy, J; Cervantes, A; Fagerberg, J; Georgoulias, V; Husseini, F; Jodrell, D; Koralewski, P; Kröning, H; Maroun, J; Marschner, N; McKendrick, J; Nowacki, MP; Pawlicki, M; Rosso, R; Scheithauer, W; Schüller, J; Seitz, JF; Stabuc, B; Tujakowski, J; Twelves, C; Van Hazel, G; Wong, A; Zaluski, J	1
Allegra, C; Sargent, DJ	1
Aquino, A; Bonmassar, E; Caraglia, M; Correale, P; Cusi, MG; Del Vecchio, MT; Formica, V; Francini, G; Giorgi, G; La Placa, M; Micheli, L; Montagnani, F; Nencini, C; Prete, S; Prete, SP; Terrosi, C; Tsang, KY	1
Bobek, V; Boubelik, M; Douglas, J; Kolostova, K; Kovarik, J; Pavlasek, J; Pinterova, D; Teyssler, P	1
Janney, LM; Waterbury, NV	1
Cassidy, J; Filipovic-Ljeskovic, I; Jelic, S; Nikolic-Tomasevic, Z; Tomasevic, Z	1
Aquino, A; Bonmassar, E; Correale, P; Cusi, MG; Del Vecchio, MT; Ferrari, F; Francini, G; Giorgi, G; Intrivici, C; Marsili, S; Micheli, L; Nencini, C; Placa, ML; Tsang, KY	1
Ahn, JS; Chang, HM; Kang, WK; Kang, YK; Kim, HK; Kim, SR; Kim, TW; Lee, KH; Park, JO; Ryoo, BY; Zang, DY	1
Almerud, A; Gubanski, M; Lideståhl, A; Lind, PA; Naucler, G	1
Cheng, XC; He, QM; Hou, JM; Hu, B; Jiang, Y; Kan, B; Li, G; Li, J; Tian, L; Wang, L; Wei, YQ; Wen, YJ; Xiao, F; Yao, B; Zhang, L; Zhang, R; Zhao, X; Zhou, Q	1
Lee, BH; Lin, X; Nelson, WG; Yegnasubramanian, S	1
Bergman, AM; Eijk, PP; Hubeek, I; Peters, GJ; Ruiz van Haperen, VW; Smid, K; van den Ijssel, P; Veerman, G; Ylstra, B	1
Bergman, AM; Costa, JL; Meijer, GA; Oudejans, CB; Peters, GJ; Smid, K; van de Wiel, MA; Ylstra, B	1
Glasmacher, A; Lamberti, C; Sauerbruch, T	1
Ershler, WB	1
Tuma, RS	1
Beham, A; Bertetto, O; Bustová, I; Cassidy, J; Cowell, W; Coxon, F; Díaz-Rubio, E; Douillard, JY; Dufour, P; Figer, A; Fountzilas, G; Garrison, LP; Jelic, S; Johnston, PG; Lesniewski-Kmak, K; Malzyner, A; Maughan, TS; McKendrick, JJ; Patel, KK; Scheithauer, W; Twelves, C	1
McAlister, H; Thompson, PI; Wijesinghe, N	1
Arai, Y; Doi, T; Hatake, K; Hyodo, I; Mishima, H; Nakagawa, K; Shirao, K; Takemiya, S; Takiuchi, H; Tamura, T; Yamaguchi, K	1
Afchain, P; André, T; de Gramont, A; Segura, C	1
Kang, BY; Kim, HA; Kim, KH; Lee, RA	1
Fujimoto-Ouchi, K; Mori, K; Onuma, E; Shirane, M; Tanaka, Y	1
Chilcott, J; Eggington, S; Paisley, S; Pandor, A; Saunders, M; Seymour, M; Sutcliffe, P; Tappenden, P	1
Aardalen, K; Doyle, L; Hibner, B; Jekic-McMullen, D; Moler, E; Rendahl, K; Salangsang, F; Shao, Y; Taverna, P	1
Eggington, S; Paisley, S; Pandor, A; Sutcliffe, P; Tappenden, P	1
Alomar, A; Dalmau, J; Fernández-Figueras, MT; Peramiquel, L; Puig, L; Roé, E	1
Bleichrodt, RP; Boerman, OC; Goldenberg, DM; Koppe, MJ; Oyen, WJ; Verhofstad, AA	1
Peters, GJ; Prins, HJ; Temmink, OH; van Gelderop, E	1
Cartwright, T; de Braud, F; Figer, A; Haller, DG; Hill, M; Lim, R; Maroun, J; McKendrick, J; Nowacki, MP; Park, YS; Price, T; Schmoll, HJ; Sirzén, F; Soler-Gonzalez, G; Tabernero, J; Topham, C; Van Cutsem, E	1
Twelves, CJ	1
Fakih, MG; Reddy, N; Yu, J	1
Wils, J	1
André, T; de Gramont, A; Larsen, AK; Louvet, C; Tournigand, C	1
Bartsch, H; Fang, Q; Hadjiolov, D; Nair, J; Sun, X	1
Huang, FY; Jiao, CL; Wu, RL; Zheng, SJ; Zheng, SP	1
Bussom, S; Cheng, YC; Lam, W; Leung, CH	1
Chang, SY; Chang, WS; Kang, CY; Kim, YJ; Kim, YS; Ko, HJ; Ko, SY; Sakaguchi, S	1
Chaudhari, AA; Kang, HS; Kim, IS; Kim, NS; Kim, TH; Lee, YJ; Park, JH; Park, SY; Seol, DW; Seol, JW	1
Ahn, E; Flores, A; Lopes, G; Quesada, J; Ribeiro, A; Rocha-Lima, CM	1
Tavares-Bello, R	1
Chau, KK; Choy, TS; Fu, YT; Law, CC; So, PF; Wong, KH	1
Gibson, DE; Szetela, AB	1
Alami, N; Belanger, S; Grieshaber, CK; Juste, S; Leyland-Jones, B; Paterson, J	1
Alexander, S; Dodds, M; Guichard, SM; Jodrell, DI; Macpherson, JS; Mayer, I; Muir, M; Reid, E	1
Douillard, JY; Dufour, P; Husseini, F; Lafuma, A; Maes, P; Perrocheau, G; Seitz, JF; Tilleul, P; Ychou, M	1
Beretta, GD; Labianca, R; Milesi, L; Mosconi, S; Pessi, MA; Quadri, A	1
Diasio, RB; Ledbetter, L; Saif, MW; Tomita, M	1
Cavallaro, G; Cosco, D; Fresta, M; Giammona, G; Licciardi, M; Paolino, D	1
Cassidy, J; Glen, H	1
Akiyama, S; Fukushima, M; Oka, T; Ooyama, A; Yamamoto, M; Zhao, HY	1
Bertoldi, I; Correale, P; Fioravanti, A; Francini, G; Miracco, C; Montagnani, F	1
Danhauser, LL; Rustum, YM	1
Boven, E; Braakhuis, BJ; Peters, GJ; Ruiz van Haperen, VW; Veerman, G	1
Bergman, AM; Braakhuis, BJ; Kuiper, CM; Peters, GJ; Ruiz van Haperen, VW; Veerman, G	1
Bergman, AM; Kuiper, CM; Peters, GJ; Ruiz van Haperen, VW; Veerman, G	1
Findenig, G; Fritzer, M; Lhotka, C; Schön, HJ; Szekeres, T	1
Boven, E; Noordhuis, P; Peters, GJ; Ruiz van Haperen, VW; Veerman, G; Vermorken, JB	1
Fujita, F; Fujita, M; Inaba, H; Taguchi, T	1
Braakhuis, BJ; Noordhuis, P; Peters, GJ; Pinedo, HM; Ruiz van Haperen, VW; Veerman, G; Vermorken, JB	1
Alvord, WG; Gazdar, AF; Gray-Goodrich, M; Koo, HM; McWilliams, MJ; Mikheev, A; Monks, A; Oie, HK; Paull, KD; Rubinstein, LV; Vande Woude, GF; Zarbl, H	1
Ariyoshi, Y; Fukuoka, M; Fukuyama, E; Furue, H; Furuse, K; Gemma, A; Harada, M; Hasegawa, K; Horikoshi, N; Kanamaru, R; Kudoh, S; Kurihara, M; Kurita, Y; Mori, K; Niitani, H; Ota, K; Taguchi, T; Tsukagoshi, S; Wakui, A; Yoneda, S	1
Boder, GB; Grindey, GB; Hertel, LW; Houghton, JA; Houghton, PJ; Merriman, RL; Rutherford, PG; Schultz, RM; Tanzer, LR	1
Eisbruch, A; Lawrence, TS; Shewach, DS	1
Coucke, PA; Guillou, L; Li, YX; Mirimanoff, RO; Sun, LQ	1
Fukase, Y; Ishikawa, T; Ishitsuka, H; Nishida, M; Sawada, N; Yoshikubo, T	1
Peters, GJ; Ruiz van Haperen, VW; van Moorsel, CJ; Veerman, G	1
McCann, J	1
Peters, GJ; Pinedo, HM; Ruiz van Haperen, VW; Smitskamp-Wilms, E; Veerman, G	1
Chang, EY; Hahn, TM; Lawrence, TS; Shewach, DS	1
Grem, JL; Kao, V; Ren, Q	1
Coucke, PA; Li, YX; Paschoud, N; Sun, LQ; Weber-Johnson, K	1
Timmerman, D	1
Cvitkovic, E; Faivre, S; Raymond, E; Woynarowski, JM	1
Mendelsohn, LG; Teng, CH; Tonkinson, JL; Worzalla, JF	1
Endo, M; Machida, H; Miura, S; Sasaki, T; Satoh, H; Yoshimura, Y	1
Aung, TT; Davis, MA; Ensminger, WD; Lawrence, TS	1
Jiang, H; Li, L; Plunkett, W; Shen, Y; Yang, LY	1
Maeda, Y; Sasaki, T	1
Czerniak, PM; Devenny, JJ; Gravallese, EM; Kerr, JS; Longtine, J; Slee, AM; Wexler, EJ; Wong, MK	1
Bhupalam, L; Fleming, DR; Glisson, SD; Goldsmith, GH; LaRocca, RV; Michelson, GD	1
Davis, MA; Hough, A; Lawrence, TS; Rehemtulla, A	1
Seitz, JF	1
Horii, I; Ishikawa, T; Ishitsuka, H; Kato, Y; Sugiyama, Y; Tsukamoto, Y; Ura, M	1
Amadori, D; De Paola, F; Frassineti, GL; Ricotti, L; Tesei, A; Zoli, W	1
Noordhuis, P; Peters, GJ; Ruiz van Haperen, VW; Veerman, G; Vermorken, JB	1
Ahluwalia, GS; Arnold, ST; Balzarini, J; Cohen, MB; Cooney, DA; Dalal, M; Johns, DG; Kang, GJ; McMahon, JB; Wilson, YA	1

Reviews

33 review(s) available for deoxycytidine and Colonic Neoplasms

Article	Year
The Adjuvant Treatment of Stage III Colon Cancer: Might Less Be More? Oncology (Williston Park, N.Y.), 2018, 09-15, Volume: 32, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Drug-Related Side Effects and Adverse Reactions; Fluorouracil; Humans; Leucovorin; Medication Therapy Management; Neoplasm Staging; Organoplatinum Compounds; Oxaloacetates; Time Factors; Treatment Outcome	2018
[Predictive and prognostic value of MSI phenotype in adjuvant colon cancer: Who and how to treat?] Bulletin du cancer, 2019, Volume: 106, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Immunotherapy; Leucovorin; Lymphocytes, Tumor-Infiltrating; Microsatellite Instability; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Phenotype; Prognosis; Pyrimidines	2019
Applications of oral fluoropyrimidines in colon cancer: their role and new directions. Journal of the National Comprehensive Cancer Network : JNCCN, 2003, Volume: 1 Suppl 3 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Enzyme Inhibitors; Fluorouracil; Humans; Oxaloacetates; Oxonic Acid; Tegafur; Uracil	2003
[A case in which dihydropyrimidine dehydrogenase deficiency was strongly suspected during adjuvant chemotherapy with capecitabine for colon cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:11 Topics: Aged; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Dihydropyrimidine Dehydrogenase Deficiency; Fatal Outcome; Fluorouracil; Humans; Male; Neutropenia; Thrombocytopenia	2013
[Early diagnosis of capecitabine-induced acute leukoencephalopathy by using diffusion-weighted MRI]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:10 Topics: Acute Disease; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diffusion Magnetic Resonance Imaging; Early Diagnosis; Female; Fluorouracil; Humans; Leukoencephalopathies; Middle Aged	2014
[A case of juvenile colon cancer with peritoneal dissemination treated effectively by use of resection and chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Colostomy; Combined Modality Therapy; Deoxycytidine; Fluorouracil; Humans; Male; Oxaloacetates; Peritoneal Neoplasms	2014
Adjuvant chemotherapy for colon cancer: the difference between Japanese and western strategies. Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Humans; Japan; Leucovorin; Lymph Node Excision; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates	2016
[A Case of Intussusception Caused by Descending Colon Cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12 Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colon, Descending; Colonic Diseases; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Intussusception; Male; Middle Aged; Oxaloacetates	2016
Colon cancer: update on adjuvant therapy. Clinical colorectal cancer, 2008, Volume: 7, Issue:3 Topics: Age Factors; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Irinotecan; Leucovorin; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Randomized Controlled Trials as Topic	2008
The role of capecitabine in the management of tumors of the digestive system. Reviews on recent clinical trials, 2009, Volume: 4, Issue:1 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Cholangiocarcinoma; Colonic Neoplasms; Deoxycytidine; Digestive System Neoplasms; Docetaxel; Esophageal Neoplasms; Fluorouracil; Gallbladder Neoplasms; Humans; Irinotecan; Liver Neoplasms; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Rectal Neoplasms; Stomach Neoplasms; Taxoids; Treatment Outcome; Vascular Endothelial Growth Factor A	2009
Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer. Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Fatigue; Female; Fluorouracil; Gastrointestinal Diseases; Hematologic Diseases; Humans; Hypertension; Irinotecan; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Proteins; Rectal Neoplasms; Retrospective Studies; Vascular Endothelial Growth Factor A	2010
Evolving treatment of advanced colon cancer. Annual review of medicine, 2009, Volume: 60 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Camptothecin; Capecitabine; Cetuximab; Colonic Neoplasms; Deoxycytidine; Disease Progression; Fluorouracil; Humans; Irinotecan; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin	2009
Capecitabine-induced severe hypertriglyceridaemia and diabetes: a case report and review of the literature. Diabetic medicine : a journal of the British Diabetic Association, 2009, Volume: 26, Issue:12 Topics: Antimetabolites, Antineoplastic; Blood Glucose; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fenofibrate; Fluorouracil; Glycated Hemoglobin; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipids; Male; Middle Aged; Treatment Outcome	2009
Renal tubular acidosis secondary to capecitabine, oxaliplatin, and cetuximab treatment in a patient with metastatic colon carcinoma: a case report and review of the literature. International journal of clinical oncology, 2010, Volume: 15, Issue:4 Topics: Acidosis, Renal Tubular; Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cetuximab; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Deoxycytidine; Female; Fluid Therapy; Fluorouracil; Humans; Liver Neoplasms; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Potassium; Treatment Outcome	2010
[Adjuvant therapy in colon cancer]. Onkologie, 2010, Volume: 33 Suppl 4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Fluorouracil; Humans; Microsatellite Instability; Neoplasm Staging; Oxaloacetates; Prognosis	2010
[Difference of colon cancer and rectal cancer-from the view of an oncological physician]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Chromosomal Instability; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Leucovorin; Microsatellite Instability; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Prognosis; Rectal Neoplasms; Risk Factors	2010
[Advances in research on capecitabine as adjuvant treatment for colon cancer after radical resection]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:11 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Semustine; Survival Rate; Vincristine	2010
[Recurrent autoimmune hemolytic anemia induced by XELOX chemotherapy for colon cancer]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2011, Volume: 108, Issue:10 Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Recurrence	2011
Preclinical and clinical studies with combinations of pemetrexed and gemcitabine. Seminars in oncology, 2002, Volume: 29, Issue:6 Suppl 18 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Colonic Neoplasms; Deoxycytidine; Drug Screening Assays, Antitumor; Folic Acid Antagonists; Gemcitabine; Glutamates; Guanine; Humans; Lung Neoplasms; Pemetrexed; Thymidylate Synthase	2002
[Chemotherapy for colon cancer]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 7 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Irinotecan; Leucovorin; Organoplatinum Compounds; Oxaliplatin; Randomized Controlled Trials as Topic; Tegafur; Treatment Outcome; Uracil	2003
Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda). European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2004, Volume: 8 Suppl 1 Topics: Alopecia; Ambulatory Care; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diarrhea; Drug Administration Schedule; Drug Monitoring; Fluorouracil; Home Care Services; Humans; Nausea; Neutropenia; Nurse's Role; Oncology Nursing; Patient Education as Topic; Safety; Stomatitis; Survival Rate; Treatment Outcome	2004
Advances in colon cancer chemotheapy: nursing implications. Home healthcare nurse, 2005, Volume: 23, Issue:3 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Cetuximab; Chemotherapy, Adjuvant; Colonic Neoplasms; Community Health Nursing; Deoxycytidine; Drug Monitoring; Fluorouracil; Home Infusion Therapy; Humans; Irinotecan; Nurse's Role; Organoplatinum Compounds; Oxaliplatin; Survival Rate; Treatment Outcome	2005
Adjuvant therapy in colon cancer: which treatment in 2005? Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16 Suppl 4 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Irinotecan; Leucovorin; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Survival Rate	2005
Capecitabine use in geriatric oncology: an analysis of current safety, efficacy, and quality of life data. Critical reviews in oncology/hematology, 2006, Volume: 58, Issue:1 Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Clinical Trials as Topic; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Geriatrics; Humans; Male; Medical Oncology; Quality of Life	2006
[Adjuvant treatment of colorectal cancer]. Bulletin du cancer, 2006, Volume: 93, Issue:7 Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Colorectal Neoplasms; Deoxycytidine; Drug Combinations; Fluorouracil; Humans; Irinotecan; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Tegafur; Uracil	2006
Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer. British journal of cancer, 2006, Nov-06, Volume: 95, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Fluorouracil; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Randomized Controlled Trials as Topic; Survival Analysis	2006
The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation. Health technology assessment (Winchester, England), 2006, Volume: 10, Issue:41 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Capecitabine; Colonic Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Drug Therapy, Combination; Fluorouracil; Organoplatinum Compounds; Oxaliplatin; Treatment Outcome; United Kingdom	2006
Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) trial: overview of efficacy, safety, and cost-effectiveness. Clinical colorectal cancer, 2006, Volume: 6, Issue:4 Topics: Antimetabolites, Antineoplastic; Capecitabine; Clinical Trials as Topic; Colonic Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Fluorouracil; Humans; Leucovorin; Neoplasm Staging	2006
Adjuvant treatment of colon cancer: past, present and future. Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:2 Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; ErbB Receptors; Fluorouracil; Humans; Infusions, Intravenous; Irinotecan; Leucovorin; Levamisole; Organoplatinum Compounds; Oxaliplatin; Survival Rate	2007
How the new oral antineoplastics affect nursing practice: capecitabine serves to illustrate. The American journal of nursing, 2007, Volume: 107, Issue:12 Topics: Administration, Oral; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Oncology Nursing; Patient Education as Topic; Prescription Fees	2007
The role of adjuvant chemotherapy in colon cancer. Surgical oncology, 2007, Volume: 16 Suppl 1 Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds; Oxaliplatin	2007
Gemcitabine-mediated radiosensitization. Seminars in oncology, 1997, Volume: 24, Issue:2 Suppl 7 Topics: Carcinoma, Squamous Cell; Clinical Trials, Phase I as Topic; Colonic Neoplasms; Deoxycytidine; Gemcitabine; Head and Neck Neoplasms; Humans; Radiation-Sensitizing Agents; Research Design; Tumor Cells, Cultured	1997
[Capecitabine--a review of its antitumor activity and toxicity in clinical studies]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:8 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colonic Neoplasms; Deoxycytidine; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Randomized Controlled Trials as Topic; Rectal Neoplasms	2000

Trials

34 trial(s) available for deoxycytidine and Colonic Neoplasms

Article	Year
Angewandte Chemie (Weinheim an der Bergstrasse, Germany), 2007, Aug-27, Volume: 119, Issue:34 Topics: 3-Hydroxybutyric Acid; Acetazolamide; Acrylates; Administration, Intravenous; Adolescent; Adult; Aerosols; Afghanistan; Aflatoxin M1; Agaricales; Aged; Aged, 80 and over; Agricultural Irrigation; Air Pollutants; alpha-L-Fucosidase; Amino Acid Sequence; Androgen Antagonists; Animals; Antibodies, Bacterial; Antigens, Bacterial; Antineoplastic Agents; Antioxidants; Apoptosis; Artifacts; Autophagy; B7-H1 Antigen; Bacterial Proteins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Bile; Bioelectric Energy Sources; Biosensing Techniques; Body Mass Index; Brain; Brazil; Breast Neoplasms; Bufo arenarum; Burkholderia; C-Reactive Protein; Cadmium; Carbon Compounds, Inorganic; Carbon-13 Magnetic Resonance Spectroscopy; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Carcinoma, Transitional Cell; Case-Control Studies; CD4-Positive T-Lymphocytes; Cell Count; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Characiformes; Child; China; Cities; Cobalt; Colonic Neoplasms; Copper Sulfate; Cross-Sectional Studies; Cyclin-Dependent Kinase Inhibitor p16; Cytokines; Deoxycytidine; Diagnosis, Differential; Digestive System; Dihydroxyphenylalanine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Barcoding, Taxonomic; DNA, Bacterial; Dose-Response Relationship, Drug; Down-Regulation; Edetic Acid; Electrochemical Techniques; Electrodes; Embolization, Therapeutic; Embryo, Nonmammalian; Environmental Monitoring; Enzyme-Linked Immunosorbent Assay; Epithelial-Mesenchymal Transition; Fatty Acids; Feces; Female; Follow-Up Studies; Food Contamination; Forkhead Box Protein M1; Fresh Water; Fungicides, Industrial; Gallium Isotopes; Gallium Radioisotopes; Gastrectomy; Gastric Bypass; Gastric Outlet Obstruction; Gastroplasty; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Bacterial; Genetic Markers; Genome, Bacterial; Genome, Mitochondrial; Glioma; Glycogen Synthase Kinase 3 beta; Goats; Gonads; Guatemala; Halomonadaceae; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hepacivirus; Histone-Lysine N-Methyltransferase; Hormones; Humans; Hydroxybutyrate Dehydrogenase; Hypersplenism; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Iran; Japan; Lactuca; Laparoscopy; Larva; Ligands; Liver Neoplasms; Lymphocyte Activation; Macrophages; Malaria; Male; Mercury; Metabolic Syndrome; Metals, Heavy; Mice; Middle Aged; Milk, Human; Mitochondria; Models, Molecular; Molecular Structure; Mothers; Multilocus Sequence Typing; Muscles; Mutation; Nanocomposites; Nanotubes, Carbon; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Cells, Circulating; Neoplastic Stem Cells; Neuroimaging; Nitriles; Nitrogen Isotopes; Non-alcoholic Fatty Liver Disease; Nuclear Magnetic Resonance, Biomolecular; Obesity; Obesity, Morbid; Oligopeptides; Oxidation-Reduction; Pancreatic Neoplasms; Particle Size; Particulate Matter; Pepsinogen A; Pesticides; Pharmacogenetics; Phosphatidylinositol 3-Kinases; Phospholipids; Phylogeny; Plasmodium ovale; Plasmodium vivax; Platelet Count; Polyhydroxyalkanoates; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postoperative Complications; Pregnancy; Prevalence; Prognosis; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Domains; Proto-Oncogene Proteins c-akt; Proton Magnetic Resonance Spectroscopy; Pseudogenes; PTEN Phosphohydrolase; Pyrazoles; Pyrimidines; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Rats, Long-Evans; Rats, Sprague-Dawley; RAW 264.7 Cells; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptor, Notch3; Receptors, G-Protein-Coupled; Receptors, Urokinase Plasminogen Activator; Recombinant Proteins; Repressor Proteins; Resveratrol; Retrospective Studies; Risk Assessment; Risk Factors; RNA, Messenger; RNA, Ribosomal, 16S; Salinity; Salvage Therapy; Seasons; Sequence Analysis, DNA; Seroepidemiologic Studies; Signal Transduction; Skin; Snails; Soluble Guanylyl Cyclase; Solutions; Spain; Species Specificity; Spheroids, Cellular; Splenic Artery; Stomach Neoplasms; Streptococcus pneumoniae; Structure-Activity Relationship; Sulfonamides; Sunlight; Surface Properties; Surgical Instruments; Surgical Wound Infection; Survival Rate; Tetrahydrouridine; Thinness; Thrombocytopenia; Tissue Distribution; Titanium; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Turkey; Ubiquinone; Urologic Neoplasms; Viral Envelope Proteins; Wastewater; Water Pollutants, Chemical; Weather; Wnt Signaling Pathway; Xenograft Model Antitumor Assays; Young Adult	2007
Safety of mFOLFOX6/XELOX as adjuvant chemotherapy after curative resection of stage III colon cancer: phase II clinical study (The FACOS study). International journal of colorectal disease, 2018, Volume: 33, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaloacetates; Withholding Treatment	2018
Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan study. Cancer, 2013, Oct-01, Volume: 119, Issue:19 Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Drug Therapy, Combination; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Panitumumab; Treatment Outcome	2013
Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors. Cancer chemotherapy and pharmacology, 2014, Volume: 74, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carboplatin; Cisplatin; Colonic Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Quinolones; Thromboembolism; Treatment Outcome; Urinary Bladder Neoplasms; Young Adult	2014
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controll The Lancet. Oncology, 2014, Volume: 15, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Meta-Analysis as Topic; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Survival Rate; Young Adult	2014
Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Nov-10, Volume: 33, Issue:32 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Proportional Hazards Models; Treatment Outcome	2015
PRODIGE 34-FFCD 1402-ADAGE: Adjuvant chemotherapy in elderly patients with resected stage III colon cancer: A randomized phase 3 trial. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2016, Volume: 48, Issue:2 Topics: Activities of Daily Living; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Digestive System Surgical Procedures; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Neoplasm Staging; Organoplatinum Compounds; Oxaloacetates; Quality of Life; Treatment Outcome	2016
Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Patient Compliance	2016
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial). Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Jul-01, Volume: 14, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunotherapy; Injections, Subcutaneous; Interleukin-2; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Recombinant Proteins; Treatment Outcome	2008
[Clinical observation of XELOX (Capecitabine puls Oxaliplatin): an adjuvant chemotherapy regimen used in stage III colorectal cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2008, Volume: 30, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Proportional Hazards Models; Rectal Neoplasms; Retrospective Studies; Survival Rate; Young Adult	2008
Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401. Journal of cancer research and clinical oncology, 2009, Volume: 135, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Colorectal Neoplasms; Deoxycytidine; Disease Progression; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Quality of Life; Rectal Neoplasms; Survival Analysis; Time Factors	2009
Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy. Journal of immunotherapy (Hagerstown, Md. : 1997), 2010, Volume: 33, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Disease Progression; Female; Fluorouracil; Forkhead Transcription Factors; Gemcitabine; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunohistochemistry; Immunotherapy; Leucovorin; Lymphocytes, Tumor-Infiltrating; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prognosis; Recombinant Proteins; Survival Analysis; T-Lymphocytes, Regulatory	2010
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer. International journal of cancer, 2011, Feb-01, Volume: 128, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Colorectal Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Rectal Neoplasms; Treatment Outcome; Young Adult	2011
Safety and pharmacokinetics of sorafenib combined with capecitabine in patients with advanced solid tumors: results of a phase 1 trial. Journal of clinical pharmacology, 2011, Volume: 51, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Benzenesulfonates; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diarrhea; Fatigue; Female; Fluorouracil; Hand-Foot Syndrome; Humans; Male; Middle Aged; Neoplasms; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib	2011
Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Apr-10, Volume: 29, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Proportional Hazards Models	2011
Adjuvant capecitabine chemotherapy using a tailored-dose strategy in elderly patients with colon cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:4 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Drug Dosage Calculations; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Multivariate Analysis; Quality of Life; Treatment Outcome	2012
Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:5 Topics: Adenocarcinoma; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Hand-Foot Syndrome; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Pharmacokinetics; Pilot Projects; Prognosis; Treatment Outcome; Young Adult	2012
Comparison of pharmacokinetics and safety profiles of two capecitabine tablet formulations in patients with colon, colorectal or breast cancer. Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:2 Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Area Under Curve; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Colorectal Neoplasms; Cross-Over Studies; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged; Tablets; Therapeutic Equivalency	2013
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial. The Lancet. Oncology, 2012, Volume: 13, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Young Adult	2012
Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:12 Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diarrhea; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Peripheral Nervous System Diseases; Safety	2003
A pilot phase II study of capecitabine in advanced or recurrent colorectal cancer. Japanese journal of clinical oncology, 2004, Volume: 34, Issue:4 Topics: Administration, Oral; Aged; Anorexia; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Hyperbilirubinemia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Rectal Neoplasms	2004
Efficacy of adjuvant capecitabine compared with bolus 5-fluorouracil/leucovorin regimen in dukes C colon cancer: results from the X-ACT trial. Clinical colorectal cancer, 2004, Volume: 4, Issue:2 Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intravenous; Leucovorin; Neoplasm Staging; Treatment Outcome	2004
Capecitabine as adjuvant treatment for stage III colon cancer. The New England journal of medicine, 2005, Jun-30, Volume: 352, Issue:26 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Survival Analysis	2005
Fluoropyrimidine therapy: hyperbilirubinemia as a consequence of hemolysis. Cancer chemotherapy and pharmacology, 2005, Volume: 56, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Hemolysis; Humans; Hyperbilirubinemia; Injections, Intravenous; Leucovorin; Middle Aged	2005
Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-10, Volume: 23, Issue:35 Topics: Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Colonic Neoplasms; Colorectal Neoplasms; Cytotoxicity, Immunologic; Deoxycytidine; Disease Progression; Female; Flow Cytometry; Fluorouracil; Gemcitabine; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunotherapy; Infusions, Intravenous; Interleukin-2; Leucovorin; Male; Organoplatinum Compounds; Oxaliplatin; T-Lymphocytes, Regulatory; Thymidylate Synthase; Treatment Outcome	2005
Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: a Korean Cancer Study Group trial. Acta oncologica (Stockholm, Sweden), 2005, Volume: 44, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diarrhea; Disease Progression; Female; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Male; Middle Aged; Neutropenia; Prodrugs; Rectal Neoplasms; Remission Induction; Survival Rate; Topoisomerase I Inhibitors; Treatment Outcome	2005
Adjuvant capecitabine is at least as effective as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer. Cancer treatment reviews, 2005, Volume: 31, Issue:8 Topics: Administration, Oral; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intravenous; Leucovorin; Male; Middle Aged; Survival Analysis; Treatment Outcome	2005
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial. British journal of cancer, 2006, Apr-24, Volume: 94, Issue:8 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Drug Costs; Fluorouracil; Health Care Costs; Health Resources; Humans; Injections, Intravenous; Leucovorin; Neoplasm Staging; Quality of Life; Remission Induction; Sensitivity and Specificity; Survival Rate; Time Factors; Treatment Outcome; United Kingdom	2006
A phase II Study of the global dose and schedule of capecitabine in Japanese patients with metastatic colorectal cancer. Japanese journal of clinical oncology, 2006, Volume: 36, Issue:7 Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Administration Schedule; Endpoint Determination; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Rectal Neoplasms	2006
Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Jan-01, Volume: 25, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Fluorouracil; Humans; Leucovorin; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Research Design; Safety; Treatment Outcome	2007
Oxaliplatin and fixed-rate infusional gemcitabine in the second-line treatment of patients with metastatic colon cancer: final results of a Phase II trial prematurely closed as a result of poor accrual. Clinical colorectal cancer, 2007, Volume: 6, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Deoxycytidine; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Gemcitabine; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Pyridines; Salvage Therapy; Survival Analysis	2007
Toxicity profile and efficacy of oral capecitabine as adjuvant chemotherapy for Chinese patients with Stage III colon cancer. Diseases of the colon and rectum, 2007, Volume: 50, Issue:12 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; China; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Prodrugs; Prospective Studies; Survival Rate; Treatment Outcome	2007
[Phase I study on DMDC]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:13 Topics: Aged; Antineoplastic Agents; Colonic Neoplasms; Deoxycytidine; Drug Administration Schedule; Esophageal Neoplasms; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Stomach Neoplasms	1996
Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies. American journal of clinical oncology, 2000, Volume: 23, Issue:4 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Deoxycytidine; Diarrhea; Esophageal Neoplasms; Exanthema; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Neoplasms, Unknown Primary; Neutropenia; Paclitaxel; Pancreatic Neoplasms; Paresthesia; Urinary Bladder Neoplasms; Vomiting	2000

Other Studies

232 other study(ies) available for deoxycytidine and Colonic Neoplasms

Article	Year
Capecitabine plus oxaliplatin in the treatment of metastatic colorectal cancer at Tygerberg Hospital: a retrospective study. The Pan African medical journal, 2022, Volume: 42 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Colorectal Neoplasms; Deoxycytidine; Disease-Free Survival; Drug Combinations; Female; Fluorouracil; Hospitals; Humans; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Rectal Neoplasms; Retrospective Studies	2022
Estimates of Overall Survival in Patients With Cancer Receiving Different Treatment Regimens: Emulating Hypothetical Target Trials in the Surveillance, Epidemiology, and End Results (SEER)-Medicare Linked Database. JAMA network open, 2020, 03-02, Volume: 3, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Colonic Neoplasms; Deoxycytidine; Erlotinib Hydrochloride; Fluorouracil; Gemcitabine; Humans; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Retrospective Studies; SEER Program; Survival Rate; United States	2020
Squamous cell carcinoma of the colon - a case report. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2020,Spring, Volume: 33, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Colonic Neoplasms; Deoxycytidine; Gemcitabine; Humans; Male	2020
Identification of PARP-1 in cancer stem cells of gastrointestinal cancers: A preliminary study. Journal of biosciences, 2021, Volume: 46 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Colonic Neoplasms; Deoxycytidine; Doxorubicin; Drug Resistance, Neoplasm; Fluorouracil; Gastrointestinal Neoplasms; Gemcitabine; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Irinotecan; Liver Neoplasms; Mice; Neoplastic Stem Cells; Pancreatic Neoplasms; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Xenograft Model Antitumor Assays	2021
Dual Gate-Controlled Therapeutics for Overcoming Bacterium-Induced Drug Resistance and Potentiating Cancer Immunotherapy. Angewandte Chemie (International ed. in English), 2021, 06-14, Volume: 60, Issue:25 Topics: Animals; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Cell Line; Ciprofloxacin; Colonic Neoplasms; Deoxycytidine; Drug Resistance, Bacterial; Escherichia coli; Gemcitabine; Humans; Mice	2021
[A Case of Advanced Transverse Colon Cancer with Nephrotic Syndrome Treated with Curative Resection and Complete Adjuvant Chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colectomy; Colon, Transverse; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Glomerulonephritis, Membranous; Humans; Laparoscopy; Nephrotic Syndrome; Oxaloacetates; Treatment Outcome	2017
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science (New York, N.Y.), 2017, 09-15, Volume: 357, Issue:6356 Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Pancreatic Ductal; Colonic Neoplasms; Deoxycytidine; Drug Resistance, Neoplasm; Gammaproteobacteria; Gemcitabine; Humans; Male; Mice; Mice, Inbred BALB C; Mycoplasma hyorhinis; Neoplasms, Experimental; Pancreatic Neoplasms	2017
Cost-effectiveness analysis of XELOX versus XELOX plus bevacizumab for metastatic colorectal cancer in a public hospital school. BMC cancer, 2017, Oct-17, Volume: 17, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brazil; Capecitabine; Colonic Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Fluorouracil; Hospitals, Public; Humans; Models, Theoretical; Neoplasm Metastasis; Oxaloacetates; Treatment Outcome	2017
Monophosphorylation by deoxycytidine kinase affects apparent cellular uptake of decitabine in HCT116 colon cancer cells. Drug metabolism and pharmacokinetics, 2017, Volume: 32, Issue:6 Topics: Antimetabolites, Antineoplastic; Azacitidine; Camptothecin; Colonic Neoplasms; Cytarabine; Decitabine; Deoxycytidine; Deoxycytidine Kinase; Equilibrative Nucleoside Transporter 1; Etoposide; Gemcitabine; HCT116 Cells; Humans; Irinotecan; Phosphorylation	2017
[A Case of Ascending Colon Cancer with Lynch Syndrome Who Underwent XELOX Adjuvant Chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colon, Ascending; Colonic Neoplasms; Colorectal Neoplasms, Hereditary Nonpolyposis; Deoxycytidine; Fluorouracil; Humans; Male; Oxaloacetates; Pedigree	2018
Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study. Clinical colorectal cancer, 2018, Volume: 17, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Chemotherapy, Adjuvant; Colon; Colonic Neoplasms; Comorbidity; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Oxaloacetates; Progression-Free Survival; Rectal Neoplasms; Rectum; Retrospective Studies	2018
Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation. European journal of radiology, 2018, Volume: 102 Topics: Ablation Techniques; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoembolization, Therapeutic; Cisplatin; Colonic Neoplasms; Colorectal Neoplasms; Deoxycytidine; Disease-Free Survival; Ethiodized Oil; Female; Gemcitabine; Humans; Hyperthermia, Induced; Irinotecan; Laser Therapy; Liver Neoplasms; Male; Microwaves; Middle Aged; Mitomycin; Neoadjuvant Therapy; Palliative Care; Prognosis; Rectal Neoplasms; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult	2018
Frondoside A Enhances the Anti-Cancer Effects of Oxaliplatin and 5-Fluorouracil on Colon Cancer Cells. Nutrients, 2018, May-01, Volume: 10, Issue:5 Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Deoxycytidine; Drug Synergism; Fluorouracil; Gemcitabine; Glycosides; HCT116 Cells; HT29 Cells; Humans; Organoplatinum Compounds; Oxaliplatin; Triterpenes	2018
Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer. British journal of cancer, 2018, Volume: 119, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaloacetates; Prognosis; Stromal Cells	2018
Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditions-benign adenomas and inflammatory bowel disease. Clinical epigenetics, 2018, Volume: 10 Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Colonic Neoplasms; Colonic Polyps; Cytidine Deaminase; Deoxycytidine; Deoxyguanosine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Down-Regulation; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Inflammatory Bowel Diseases; Middle Aged; Mixed Function Oxygenases; Proto-Oncogene Proteins; Tissue Array Analysis	2018
A molecular basis for the synergy between 17‑allylamino‑17‑demethoxy geldanamycin with Capecitabine and Irinotecan in human colorectal cancer cells through VEFG and MMP-9 gene expression. Gene, 2019, Feb-05, Volume: 684 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzoquinones; Camptothecin; Capecitabine; Colonic Neoplasms; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Gene Expression; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Irinotecan; Lactams, Macrocyclic; Matrix Metalloproteinase 9; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A	2019
Hyaluronic acid conjugated multi-walled carbon nanotubes for colon cancer targeting. International journal of biological macromolecules, 2019, Feb-15, Volume: 123 Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Deoxycytidine; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Folic Acid; Gemcitabine; Humans; Hyaluronic Acid; Nanotubes, Carbon; Rats	2019
Recombinant deoxyribonucleoside kinase from Drosophila melanogaster can improve gemcitabine based combined gene/chemotherapy for targeting cancer cells. Bosnian journal of basic medical sciences, 2019, Nov-08, Volume: 19, Issue:4 Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Deoxycytidine; Drosophila melanogaster; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Gemcitabine; Genetic Therapy; Genetic Vectors; HCT116 Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms; MCF-7 Cells; Phosphotransferases (Alcohol Group Acceptor); Recombinant Proteins; Substrate Specificity; Transfection	2019
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant. Medicine, 2019, Volume: 98, Issue:21 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Oxaloacetates	2019
Cost analysis of adjuvant therapy with XELOX or FOLFOX4 for colon cancer. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2013, Volume: 15, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; China; Colonic Neoplasms; Cost of Illness; Deoxycytidine; Female; Fluorouracil; Hospitalization; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaloacetates; Retrospective Studies; Treatment Outcome	2013
[Study of tolerability of capecitabine in postoperative adjuvant chemotherapy in colon cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:3 Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged	2013
Fluoropyrimidine toxicity in patients with dihydropyrimidine dehydrogenase splice site variant: the need for further revision of dose and schedule. Internal and emergency medicine, 2013, Volume: 8, Issue:5 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Capecitabine; Colonic Neoplasms; Deoxycytidine; Dihydropyrimidine Dehydrogenase Deficiency; Dose-Response Relationship, Drug; Fluorouracil; Head and Neck Neoplasms; Heterozygote; Humans; Male; Mutation; Patient Selection; Polymerase Chain Reaction	2013
Enhanced antitumor efficacy of gemcitabine-loaded temperature-sensitive liposome by hyperthermia in tumor-bearing mice. Drug development and industrial pharmacy, 2014, Volume: 40, Issue:4 Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Apoptosis; Caspase 3; Caspase 7; Chromatin; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; DNA Fragmentation; Dose-Response Relationship, Drug; Gemcitabine; Hyperthermia, Induced; Inhibitory Concentration 50; Liposomes; Mice; Mice, Inbred BALB C; Temperature	2014
Triplex-forming oligonucleotides targeting c-MYC potentiate the anti-tumor activity of gemcitabine in a mouse model of human cancer. Molecular carcinogenesis, 2014, Volume: 53, Issue:9 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chromatin Immunoprecipitation; Colonic Neoplasms; Deoxycytidine; DNA, Neoplasm; Drug Synergism; Female; Gemcitabine; Humans; Mice; Mice, Nude; Oligonucleotides; Proto-Oncogene Proteins c-myc; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2014
HMGB1 recruits myeloid derived suppressor cells to promote peritoneal dissemination of colon cancer after resection. Biochemical and biophysical research communications, 2013, Jun-28, Volume: 436, Issue:2 Topics: Animals; Antimetabolites, Antineoplastic; Ascitic Fluid; Cell Line, Tumor; Colonic Neoplasms; Deoxycytidine; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gemcitabine; HMGB1 Protein; Mice; Mice, Inbred BALB C; Myeloid Cells; Peritoneal Neoplasms; Recombinant Proteins	2013
[A case of relapsed colon cancer successfully treated by capecitabine]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:4 Topics: Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Liver Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Sigmoid Neoplasms; Splenic Neoplasms	2013
[A case of metastatic colon cancer effectively treated by XELOX and IRIS]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Combinations; Female; Fluorouracil; Humans; Irinotecan; Liver Neoplasms; Oxaloacetates; Oxonic Acid; Tegafur; Tomography, X-Ray Computed	2013
Gemcitabine-mediated tumour regression and p53-dependent gene expression: implications for colon and pancreatic cancer therapy. Cell death & disease, 2013, Sep-05, Volume: 4 Topics: 14-3-3 Proteins; Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Cell Line, Tumor; Chromium; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Deoxycytidine; DNA Damage; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, SCID; Models, Biological; Pancreatic Neoplasms; Protein Biosynthesis; Proto-Oncogene Proteins; Remission Induction; Transcription, Genetic; Tumor Suppressor Protein p53	2013
Paraneoplastic stiff person syndrome associated with colon cancer misdiagnosed as idiopathic Parkinson's disease worsened after capecitabine therapy. World journal of surgical oncology, 2013, Sep-12, Volume: 11 Topics: Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diagnostic Errors; Drug-Related Side Effects and Adverse Reactions; Female; Fluorouracil; Humans; Middle Aged; Parkinson Disease; Prognosis; Stiff-Person Syndrome	2013
Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24 Suppl 6 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoembryonic Antigen; Chemotherapy, Adjuvant; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 18; Colonic Neoplasms; Colonoscopy; Deoxycytidine; Early Detection of Cancer; Europe; Female; Fluorouracil; Follow-Up Studies; Humans; Intestinal Mucosa; Leucovorin; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Occult Blood; Organoplatinum Compounds; Oxaloacetates; Risk; Risk Assessment; Risk Factors; Sigmoidoscopy; Treatment Outcome	2013
Comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro. Radiation oncology (London, England), 2013, Nov-06, Volume: 8 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Carbon; Cell Cycle; Cell Line, Tumor; Cell Separation; Chemoradiotherapy; Cisplatin; Colonic Neoplasms; Deoxycytidine; Dose-Response Relationship, Radiation; Drug Screening Assays, Antitumor; Flow Cytometry; Gemcitabine; Glioblastoma; Humans; Ions; Lung Neoplasms; Paclitaxel; Pancreatic Neoplasms; Photons; Propidium; Radiotherapy; Relative Biological Effectiveness; Time Factors	2013
[A case wherein bevacizumab/XELOX combination therapy was remarkably effective for the treatment of extensive dissemination in advanced colon cancer, and the primary lesion could be resected]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:11 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Fluorouracil; Humans; Male; Middle Aged; Oxaloacetates; Peritoneal Neoplasms	2013
Fluoropyrimidine toxicity in patients with dihydropyrimidine dehydrogenase (DPD) splice site variant: the need for further revision of dose and schedule. Internal and emergency medicine, 2014, Volume: 9, Issue:4 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Colonic Neoplasms; Deoxycytidine; Dihydropyrimidine Dehydrogenase Deficiency; Fluorouracil; Head and Neck Neoplasms; Humans; Male	2014
[Efficacy and safety of bevacizumab (BEV) plus chemotherapeutic agents in the treatment of metastatic colorectal cancer, mCRC]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2013, Volume: 35, Issue:8 Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Hemorrhage; Humans; Hypertension; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaloacetates; Proteinuria; Rectal Neoplasms; Remission Induction; Young Adult	2013
[A case of a recurrent hepatic metastasis occurred after curative resection of ascending colon cancer and a hepatic metastasis responding completely to capecitabine plus bevacizumab]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12 Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Chemotherapy, Adjuvant; Colectomy; Colon, Ascending; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Liver Neoplasms; Male; Recurrence	2013
Retrospective comparison of CAPOX and FOLFOX dose intensity, toxicity, and clinical outcomes in the treatment of metastatic colon cancer. Journal of gastrointestinal cancer, 2014, Volume: 45, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Retrospective Studies; Survival Rate	2014
[A case of endocrine cell carcinoma of the ascending colon with liver metastasis treated with hepatectomy after excision of the primary lesion and systemic chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:1 Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colon, Ascending; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Endocrine Gland Neoplasms; Fluorouracil; Hepatectomy; Humans; Liver Neoplasms; Male; Organoplatinum Compounds; Oxaliplatin	2014
Colon carcinoma treated with oxaliplatin and capecitabine in a 12-year-old child. World journal of pediatrics : WJP, 2014, Volume: 10, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Child; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Humans; Oxaloacetates	2014
Therapeutic modalities of squalenoyl nanocomposites in colon cancer: an ongoing search for improved efficacy. ACS nano, 2014, Mar-25, Volume: 8, Issue:3 Topics: Animals; Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Deoxycytidine; Drug Carriers; Drug Design; Gemcitabine; Humans; Intracellular Space; Mice; Nanocomposites; Squalene; Stilbenes; Xenograft Model Antitumor Assays	2014
CAPOX associated with toxicities of higher grade but improved disease-free survival when compared with FOLFOX in the adjuvant treatment of stage III colon cancer. Clinical colorectal cancer, 2014, Volume: 13, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Survival Rate	2014
To treat or not to treat: who should decide? The oncologist, 2014, Volume: 19, Issue:4 Topics: Aged; Capecitabine; Colonic Neoplasms; Decision Making; Deoxycytidine; Fluorouracil; Humans; Male; Organoplatinum Compounds; Oxaliplatin; Patient Participation; Quality of Life; Treatment Refusal	2014
Anti-angiogenesis participates in antitumor effects of metronomic capecitabine on colon cancer. Cancer letters, 2014, Jul-28, Volume: 349, Issue:2 Topics: Administration, Metronomic; Animals; Antimetabolites, Antineoplastic; Capecitabine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Fluorouracil; HCT116 Cells; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Random Allocation; Thrombospondin 1; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2014
Increased mean corpuscular volume of red blood cells in patients treated with capecitabine for advanced breast and colon cancer. Chemotherapy, 2013, Volume: 59, Issue:5 Topics: Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease Progression; Erythrocyte Indices; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Treatment Outcome	2013
Inferior oncological prognosis of surgery without oral chemotherapy for stage III colon cancer in clinical settings. World journal of surgical oncology, 2014, May-10, Volume: 12 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Tegafur; Uracil; Young Adult	2014
Paclitaxel and gemcitabine combinational drug-loaded mucoadhesive delivery system in the treatment of colon cancers. Drug research, 2015, Volume: 65, Issue:4 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Line, Tumor; Cell Survival; Chitosan; Colonic Neoplasms; Deoxycytidine; Drug Carriers; Drug Liberation; Drug Therapy, Combination; Gemcitabine; Humans; Mice; Nanoparticles; Paclitaxel; Succinic Anhydrides; Survival Rate; Xenograft Model Antitumor Assays	2015
The key role of calreticulin in immunomodulation induced by chemotherapeutic agents. International journal of clinical oncology, 2015, Volume: 20, Issue:2 Topics: Animals; Antigens, Surface; Antineoplastic Agents; Apoptosis; Calreticulin; Camptothecin; Carcinoma, Lewis Lung; CD3 Complex; Cell Line, Tumor; Cell Survival; Cisplatin; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Histocompatibility Antigens Class I; Humans; Immunomodulation; Lymphocyte Count; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mitomycin; Mitoxantrone; Neoplasm Transplantation; Neoplasms, Experimental; Protein Transport; T-Lymphocytes; Tumor Microenvironment	2015
Colon cancer, version 3.2014. Journal of the National Comprehensive Cancer Network : JNCCN, 2014, Volume: 12, Issue:7 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Cetuximab; Colonic Neoplasms; Deoxycytidine; Disease Progression; Fluorouracil; GTP Phosphohydrolases; Humans; Leucovorin; Liver Neoplasms; Membrane Proteins; Organoplatinum Compounds; Oxaloacetates; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); ras Proteins; Treatment Outcome	2014
Pseudocirrhosis after anti-EGFR-based neoadjuvant therapy for hepatic metastasis from colon cancer: a different point of view. Clinical colorectal cancer, 2014, Volume: 13, Issue:3 Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Cetuximab; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; ErbB Receptors; Fluorouracil; Humans; Leucovorin; Liver Cirrhosis; Liver Neoplasms; Male; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin	2014
Efficacy and safety of single agent or combination adjuvant chemotherapy in elderly patients with colon cancer: a Canadian cancer institute experience. Clinical colorectal cancer, 2014, Volume: 13, Issue:3 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Canada; Capecitabine; Chemotherapy, Adjuvant; Choice Behavior; Colonic Neoplasms; Comorbidity; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Insurance Coverage; Insurance, Pharmaceutical Services; Leucovorin; Male; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Patient Preference; Retrospective Studies; Survival Rate; Vitamin B Complex	2014
Adaptation of international guidelines for metastatic colorectal cancer: an asian consensus. Clinical colorectal cancer, 2014, Volume: 13, Issue:3 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Asia; Bevacizumab; Camptothecin; Capecitabine; Cetuximab; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Drug Combinations; ErbB Receptors; Fluorouracil; Guideline Adherence; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Metastasectomy; Neoplasm Staging; Organoplatinum Compounds; Oxaloacetates; Oxonic Acid; Panitumumab; Practice Guidelines as Topic; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Rectal Neoplasms; Tegafur; Tomography, X-Ray Computed	2014
Acute coronary artery thrombosis and vasospasm following capecitabine in conjunction with oxaliplatin treatment for cancer. BMJ case reports, 2014, 09-22, Volume: 2014 Topics: Adult; Antineoplastic Agents; Capecitabine; Colonic Neoplasms; Coronary Angiography; Coronary Thrombosis; Coronary Vasospasm; Deoxycytidine; Drug Therapy, Combination; Electrocardiography; Female; Fluorouracil; Humans; Organoplatinum Compounds; Oxaliplatin	2014
[Survey of the current status of capecitabine-induced hypertriglyceridemia]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:9 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Hypertriglyceridemia; Male; Middle Aged; Retrospective Studies; Stomach Neoplasms	2014
[Capecitabine-induced subacute cutaneous lupus: a case report]. Annales de dermatologie et de venereologie, 2014, Volume: 141, Issue:10 Topics: Adverse Drug Reaction Reporting Systems; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diagnosis, Differential; Female; Fluorouracil; France; Humans; Lupus Erythematosus, Cutaneous; Middle Aged	2014
Gemcitabine plus capecitabine (Gem-Cape) biweekly in chemorefractory metastatic colorectal cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2015, Volume: 17, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Peritoneal Neoplasms; Rectal Neoplasms; Retreatment; Retrospective Studies; Survival Rate	2015
Cost-effectiveness analysis of colon cancer treatments from MOSIAC and No. 16968 trials. World journal of gastroenterology, 2014, Dec-21, Volume: 20, Issue:47 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; China; Clinical Trials as Topic; Colonic Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Drug Costs; Female; Fluorouracil; Humans; Leucovorin; Male; Markov Chains; Middle Aged; Models, Economic; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Quality-Adjusted Life Years; Time Factors; Treatment Outcome	2014
XELOX plus bevacizumab vs. FOLFIRI plus bevacizumab treatment for first-line chemotherapy in metastatic colon cancer: a retrospective study of the Anatolian Society of Medical Oncology. Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:23 Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Camptothecin; Capecitabine; Carcinoma; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Oxaloacetates; Retrospective Studies; Treatment Outcome	2014
[Blindness and symmetrical neurological deficit in a patient with colon cancer receiving adjuvant chemotherapy: is it always cancer?]. Harefuah, 2014, Volume: 153, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Blindness; Brain Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Posterior Leukoencephalopathy Syndrome; Seizures; Steroids	2014
Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival. Cancer science, 2015, Volume: 106, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; beta-Thromboglobulin; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Organoplatinum Compounds; Receptors, CXCR4; Receptors, Interleukin-8B; Signal Transduction	2015
[Systemic chemotherapy and surgery for recurrent metachronous liver metastases with peritoneal dissemination from triple colon cancers-a case report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:13 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Fluorouracil; Hepatectomy; Humans; Liver Neoplasms; Male; Neoplasms, Multiple Primary; Oxaloacetates; Peritoneal Neoplasms; Recurrence	2014
Observational study of adjuvant therapy with capecitabine in colon cancer. Current medical research and opinion, 2015, Volume: 31, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Humans; Male; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Rectal Neoplasms; Retrospective Studies	2015
[Adjuvant chemotherapy with capecitabine for colon cancer - a case series]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged; Prognosis; Young Adult	2014
[A case of descending colon cancer with multiple liver metastases effectively treated with capecitabine/oxaliplatin (CapeOX) and bevacizumab]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colon, Descending; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Liver Neoplasms; Middle Aged; Organoplatinum Compounds; Oxaliplatin	2014
[A case of metastatic gastric cancer originating from transverse colon cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colon, Transverse; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Lymphatic Metastasis; Middle Aged; Oxaloacetates; Peritoneal Neoplasms; Recurrence; Stomach Neoplasms	2014
[A case of early gastric cancer completely responding to adjuvant chemotherapy for advanced colon cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colectomy; Colon, Ascending; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Male; Neoplasms, Multiple Primary; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms	2014
[The present status of CapeOX as adjuvant chemotherapy for colorectal cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Hand-Foot Syndrome; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Rectal Neoplasms; Retrospective Studies	2015
Photochemical tissue penetration via photosensitizer for effective drug penetration in a non-vascular tumor. Biomaterials, 2015, Volume: 52 Topics: Animals; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Deoxycytidine; Drug Delivery Systems; Fluorescein; Gemcitabine; Light; Male; Materials Testing; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Photochemotherapy; Photosensitizing Agents; Polyurethanes; Singlet Oxygen; Surface Properties	2015
[A Case of Gastrointestinal Metastases of Breast Cancer Effectively Treated with Gemcitabine and Paclitaxel Combination Chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colonic Neoplasms; Deoxycytidine; Female; Gemcitabine; Humans; Intestinal Obstruction; Middle Aged; Paclitaxel; Stomach Neoplasms	2015
Local bacteria affect the efficacy of chemotherapeutic drugs. Scientific reports, 2015, Sep-29, Volume: 5 Topics: Animals; Antineoplastic Agents; Aziridines; Biotransformation; Cladribine; Colonic Neoplasms; Deoxycytidine; Escherichia coli; Female; Gemcitabine; Injections, Intralesional; Injections, Subcutaneous; Listeria; Mice; Neoplasm Transplantation; Skin; Treatment Outcome; Vidarabine	2015
Unilateral Capecitabine-related Hand-foot Syndrome. Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:21 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Hand-Foot Syndrome; Humans; Liver Neoplasms; Male; Middle Aged; Risk Factors; Syndrome	2015
LY2603618, a selective CHK1 inhibitor, enhances the anti-tumor effect of gemcitabine in xenograft tumor models. Investigational new drugs, 2016, Volume: 34, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Checkpoint Kinase 1; Colonic Neoplasms; Deoxycytidine; DNA Damage; Female; Gemcitabine; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Phenylurea Compounds; Protein Kinase Inhibitors; Protein Kinases; Pyrazines; Xenograft Model Antitumor Assays	2016
Specific microRNAs as novel biomarkers for combination chemotherapy resistance detection of colon adenocarcinoma. European journal of medical research, 2015, Dec-02, Volume: 20 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Resistance, Neoplasm; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Male; MicroRNAs; Middle Aged; Oxaloacetates; Retrospective Studies; ROC Curve	2015
Adenovirus-Mediated E2F-1 Gene Transfer Augments Gemcitabine-Induced Apoptosis in Human Colon Cancer Cells. Clinical laboratory, 2015, Volume: 61, Issue:10 Topics: Adenoviridae; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Deoxycytidine; DNA Fragmentation; E2F1 Transcription Factor; Gemcitabine; Gene Transfer Techniques; Humans; Inhibitory Concentration 50; Microscopy, Fluorescence; Mutation; Tumor Suppressor Protein p53	2015
Self-identification and management of hand-foot syndrome (HFS): effect of a structured teaching program on patients receiving capecitabine-based chemotherapy for colon cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease Management; Female; Fluorouracil; Hand-Foot Syndrome; Humans; Incidence; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Patient Education as Topic; Quality of Life; Self Care; Young Adult	2016
[A Case of Primary Cancer of the Pancreas and Colon Treated with the Combination of Gemcitabine and TS-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Deoxycytidine; Gemcitabine; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Silicates; Titanium; Treatment Outcome	2016
Intensity of adjuvant chemotherapy regimens and grade III-V toxicities among elderly stage III colon cancer patients. European journal of cancer (Oxford, England : 1990), 2016, Volume: 61 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Male; Multivariate Analysis; Netherlands; Organoplatinum Compounds; Oxaliplatin	2016
Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model. PloS one, 2016, Volume: 11, Issue:7 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Deoxycytidine; DNA Damage; DNA Repair; Gemcitabine; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Lead Radioisotopes; Mice; Trastuzumab	2016
Gemcitabine-based polymer-drug conjugate for enhanced anticancer effect in colon cancer. International journal of pharmaceutics, 2016, Nov-20, Volume: 513, Issue:1-2 Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Cell Survival; Colonic Neoplasms; Delayed-Action Preparations; Deoxycytidine; Drug Carriers; Drug Liberation; Gemcitabine; HT29 Cells; Humans; Mice, Nude; Micelles; Polyesters; Polyethylene Glycols; Rats; Tumor Burden	2016
[A Case of Aortoesophageal Fistula Rupture Due to Descending Thoracic Aortic Dissection with Recurrent Colon Cancer during Chemotherapy Containing Bevacizumab]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aortic Diseases; Bevacizumab; Capecitabine; Colonic Neoplasms; Deoxycytidine; Esophageal Fistula; Fatal Outcome; Female; Fluorouracil; Humans; Oxaloacetates; Postoperative Complications; Recurrence	2016
[A Case Report of Clinical Complete Response with Chemotherapy for Descending Colon Cancer Complicated with Severe Pulmonary Dysfunction]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colon, Descending; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Lung Diseases; Male; Oxaloacetates; Pneumonectomy; Treatment Outcome	2016
Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer : economic evaluation in an Italian NHS setting. Clinical drug investigation, 2008, Volume: 28, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Colonic Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Female; Fluorouracil; Health Care Costs; Humans; Infusions, Parenteral; Italy; Leucovorin; Male; Middle Aged; National Health Programs; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Young Adult	2008
Complete remission in a colon cancer patient with a large, irresectable liver metastasis after XELOX/cetuximab/bevacizumab treatment. Onkologie, 2008, Volume: 31, Issue:8-9 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Cetuximab; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Oxaloacetates; Treatment Failure; Treatment Outcome	2008
Complete remission of unresectable colon cancer after preoperative chemotherapy selected by adenosine triphosphate-based chemotherapy response assay. Journal of Korean medical science, 2008, Volume: 23, Issue:5 Topics: Adenosine Triphosphate; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Liver Neoplasms; Male; Medical Oncology; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Remission Induction; Treatment Outcome	2008
Sequential or combination chemotherapy for a patient with mCRC? Cancer treatment reviews, 2008, Volume: 34 Suppl 2 Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Therapy, Combination; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male	2008
Chemotherapy side-effect management using mobile phones. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2008, Volume: 2008 Topics: Adverse Drug Reaction Reporting Systems; Aged; Capecitabine; Cell Phone; Colonic Neoplasms; Deoxycytidine; Drug Therapy, Computer-Assisted; England; Female; Fluorouracil; Humans; Male; Middle Aged; Remote Consultation	2008
Oxaliplatin-mediated autoimmune thrombocytopenia. Clinical colorectal cancer, 2009, Volume: 8, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Purpura, Thrombocytopenic, Idiopathic	2009
Coexistence Hodgkin's lymphoma and colonic adenocarcinoma: a case report. Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease Progression; Fatal Outcome; Fluorouracil; Gastrointestinal Hemorrhage; Hodgkin Disease; Humans; Immunohistochemistry; Lymph Nodes; Male; Oxaloacetates; Tomography, X-Ray Computed	2010
Assessing software impact on clinical workflow and resource utilization. Studies in health technology and informatics, 2009, Volume: 143 Topics: Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Efficiency, Organizational; Evaluation Studies as Topic; Fluorouracil; Health Resources; Humans; Medical Oncology; Medication Systems, Hospital; Pharmacy Service, Hospital; Software	2009
Palmar-plantar hyperpigmentation with capecitabine in adjuvant colon cancer. Journal of gastrointestinal cancer, 2008, Volume: 39, Issue:1-4 Topics: Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Hyperpigmentation; Male; Middle Aged	2008
Acquired Fanconi syndrome after treatment with capecitabine, irinotecan, and bevacizumab. The Annals of pharmacotherapy, 2009, Volume: 43, Issue:7 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fanconi Syndrome; Female; Fluorouracil; Humans; Irinotecan	2009
Capecitabine-induced cardiotoxicity: when to suspect? How to manage? A case report. Journal of cardiovascular medicine (Hagerstown, Md.), 2009, Volume: 10, Issue:9 Topics: Angina Pectoris; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Coronary Angiography; Coronary Vasospasm; Deoxycytidine; Diltiazem; Electrocardiography; Fluorouracil; Heart Rate; Humans; Male; Middle Aged; Tachycardia, Ventricular; Vasodilator Agents	2009
Does stent placement for advanced colon cancer increase the risk of perforation during bevacizumab-based therapy? Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2009, Volume: 7, Issue:11 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Intestinal Perforation; Organoplatinum Compounds; Oxaliplatin; Risk Assessment; Stents	2009
Cost-effectiveness analysis of capecitabine compared with bolus 5-fluorouracil/l-leucovorin for the adjuvant treatment of colon cancer in Japan. PharmacoEconomics, 2009, Volume: 27, Issue:7 Topics: Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Female; Fluorouracil; Humans; Japan; Leucovorin; Male; Markov Chains; Middle Aged	2009
Cancer and chemotherapy. BMJ (Clinical research ed.), 2009, Aug-24, Volume: 339 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Interpersonal Relations; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Social Support	2009
The necessity of chemotherapy in T3N0M0 colon cancer without risk factors. American journal of surgery, 2009, Volume: 198, Issue:3 Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Retrospective Studies; Risk Factors; Survival Rate; Tegafur; Treatment Outcome; Uracil	2009
[Prognostic analysis of 443 cases of stage II colorectal cancer and the value of adjuvant chemotherapy]. Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Child; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Humans; Intestinal Obstruction; Intestinal Perforation; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaloacetates; Proportional Hazards Models; Rectal Neoplasms; Retrospective Studies; Survival Rate; Young Adult	2009
[Clinical significance of a transient increase in carcinoembryonic antigen and carbohydrate antigen 19-9 in patients with metastatic colorectal cancer receiving chemotherapy]. Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:9 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Camptothecin; Capecitabine; Carcinoembryonic Antigen; Child; Colonic Neoplasms; Deoxycytidine; Disease Progression; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Rectal Neoplasms; Remission Induction; Young Adult	2009
Artificial neural networks for prediction of response to chemoradiation in HT29 xenografts. International journal of radiation oncology, biology, physics, 2009, Oct-01, Volume: 75, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Diffusion Magnetic Resonance Imaging; Feasibility Studies; Fluorouracil; HT29 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neural Networks, Computer; Organoplatinum Compounds; Oxaliplatin; Random Allocation; Time Factors; Transplantation, Heterologous; Treatment Outcome; Tumor Burden	2009
Disulfiram/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines. Cancer letters, 2010, Apr-01, Volume: 290, Issue:1 Topics: Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Colonic Neoplasms; Copper; Deoxycytidine; Disulfiram; Drug Resistance, Neoplasm; Drug Synergism; Electrophoretic Mobility Shift Assay; Female; Fluorouracil; Gemcitabine; Humans; NF-kappa B; Ribonucleoside Diphosphate Reductase; Thymidylate Synthase; Tumor Suppressor Proteins	2010
Synthesis, crystallization, and biological evaluation of an orally active prodrug of gemcitabine. Journal of medicinal chemistry, 2009, Nov-26, Volume: 52, Issue:22 Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Transformation, Neoplastic; Colonic Neoplasms; Crystallization; Crystallography, X-Ray; Cytidine; Deoxycytidine; Gemcitabine; Humans; Mice; Models, Molecular; Molecular Conformation; Prodrugs; Solubility	2009
Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model. International journal of colorectal disease, 2010, Volume: 25, Issue:2 Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease Models, Animal; Gemcitabine; Hypothermia, Induced; Infusions, Parenteral; Male; Mitomycin; Neoplasm Transplantation; Peritoneal Neoplasms; Photochemotherapy; Rats; Taurine; Therapeutic Irrigation; Thiadiazines; Time Factors; Tumor Burden	2010
Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses. British journal of cancer, 2010, Jan-05, Volume: 102, Issue:1 Topics: Animals; Antigen Presentation; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Colonic Neoplasms; Culture Media, Conditioned; Cyclophosphamide; Cytokines; Cytotoxicity, Immunologic; Dendritic Cells; Deoxycytidine; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; HLA-A1 Antigen; Humans; Lymphocyte Activation; Male; Mice; Mice, Nude; Organoplatinum Compounds; Oxaliplatin; Premedication; T-Lymphocytes, Cytotoxic	2010
Sickle cell crisis in a patient receiving capecitabine chemotherapy. Clinical oncology (Royal College of Radiologists (Great Britain)), 2010, Volume: 22, Issue:1 Topics: Adenocarcinoma; Anemia, Sickle Cell; Antineoplastic Agents, Phytogenic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Male; Middle Aged; Pain	2010
Atypical presentation of acute neurotoxicity secondary to oxaliplatin. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2010, Volume: 16, Issue:4 Topics: Adenocarcinoma; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Leg; Middle Aged; Muscle Cramp; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Paresthesia; Treatment Outcome	2010
Compliance and effective management of the hand-foot syndrome in colon cancer patients receiving capecitabine as adjuvant chemotherapy. Yonsei medical journal, 2009, Dec-31, Volume: 50, Issue:6 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Male; Middle Aged; Retrospective Studies; Syndrome	2009
MGMT -535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy. Journal of cancer research and clinical oncology, 2010, Volume: 136, Issue:8 Topics: Amino Acid Substitution; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chromosome Mapping; Colonic Neoplasms; Colorectal Neoplasms; Deoxycytidine; DNA Modification Methylases; DNA Repair; DNA Repair Enzymes; Female; Fluorouracil; Genotype; Humans; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prognosis; Rectal Neoplasms; Tumor Suppressor Proteins	2010
MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil. Cancer biology & therapy, 2010, Apr-01, Volume: 9, Issue:7 Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Camptothecin; Capecitabine; Caspases; Cell Cycle Proteins; Cell Proliferation; Colonic Neoplasms; Deoxycytidine; DNA Damage; Doxorubicin; Flow Cytometry; Fluorouracil; Glutamates; Guanine; Histones; Humans; Immunoenzyme Techniques; Mitomycin; Nuclear Proteins; Pemetrexed; Phosphorylation; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Pyrimidinones; Rats; Rats, Inbred F344; Rats, Nude; Xenograft Model Antitumor Assays	2010
Hepatic arterial infusion of gemcitabine-oxaliplatin in a large metastasis from colon cancer. World journal of gastroenterology, 2010, Mar-07, Volume: 16, Issue:9 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Catheter Ablation; Colonic Neoplasms; Deoxycytidine; Gemcitabine; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Tomography, X-Ray Computed; Treatment Outcome	2010
Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC). European journal of cancer (Oxford, England : 1990), 2010, Volume: 46, Issue:9 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibody-Dependent Cell Cytotoxicity; Antineoplastic Agents; Blotting, Western; Camptothecin; Cell Line, Tumor; Cetuximab; Colonic Neoplasms; Deoxycytidine; Drug Synergism; ErbB Receptors; Fluorouracil; Gemcitabine; Genes, ras; Humans; Irinotecan; Killer Cells, Lymphokine-Activated; Mutation; Panitumumab; Up-Regulation	2010
[Chemotherapy of colonic cancer]. Soins; la revue de reference infirmiere, 2010, Issue:743 Topics: Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease Progression; ErbB Receptors; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds	2010
Aberrant repair of etheno-DNA adducts in leukocytes and colon tissue of colon cancer patients. Free radical biology & medicine, 2010, Sep-15, Volume: 49, Issue:6 Topics: Adult; Aged; Carcinoma; Case-Control Studies; Colon; Colonic Neoplasms; Deoxyadenosines; Deoxycytidine; DNA Adducts; DNA Glycosylases; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; Female; Humans; Leukocytes, Mononuclear; Lipid Peroxidation; Middle Aged; Mutation; Thymine DNA Glycosylase	2010
Adherence with oral chemotherapy: results from a qualitative study of the behaviour and representations of patients and oncologists. European journal of cancer care, 2011, Volume: 20, Issue:4 Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Medication Adherence; Middle Aged; Practice Patterns, Physicians'; Qualitative Research; Risk Factors	2011
The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies. International journal of cancer, 2011, Mar-15, Volume: 128, Issue:6 Topics: Antimalarials; Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Artesunate; Blotting, Western; Breast Neoplasms; Cell Proliferation; Colonic Neoplasms; Deoxycytidine; Female; Flow Cytometry; Gemcitabine; Humans; Lenalidomide; Lung Neoplasms; Organoplatinum Compounds; Oxaliplatin; Thalidomide; Tumor Cells, Cultured	2011
A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients. British journal of cancer, 2010, Oct-26, Volume: 103, Issue:9 Topics: Aged; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cancer Vaccines; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Dendritic Cells; Deoxycytidine; Fluorouracil; Humans; Hypersensitivity, Delayed; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Pilot Projects; T-Lymphocytes	2010
E phage gene transfection enhances sensitivity of lung and colon cancer cells to chemotherapeutic agents. International journal of oncology, 2010, Volume: 37, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Carcinoma; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Genetic Therapy; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Paclitaxel; Transfection; Viral Proteins	2010
Exudative, nonhealing scalp: a complication of systemic chemotherapy with capecitabine and bevacizumab. Archives of dermatology, 2011, Volume: 147, Issue:1 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Eruptions; Fluorouracil; Humans; Male; Melanoma; Scalp Dermatoses; Severity of Illness Index; Skin Neoplasms	2011
Capecitabine-induced, nonneutropenic enterocolitis. Journal of gastrointestinal cancer, 2011, Volume: 42, Issue:4 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Capecitabine; Cecal Neoplasms; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Enterocolitis; Fluorouracil; Humans; Male; Middle Aged; Tomography, X-Ray Computed	2011
Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer. British journal of cancer, 2011, Mar-01, Volume: 104, Issue:5 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aurora Kinase B; Aurora Kinases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Deoxycytidine; Drug Screening Assays, Antitumor; Gemcitabine; Humans; Male; Mice; Mice, Nude; Organophosphates; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Protein Serine-Threonine Kinases; Quinazolines; Xenograft Model Antitumor Assays	2011
An acetylated polysaccharide-PTFE membrane-covered stent for the delivery of gemcitabine for treatment of gastrointestinal cancer and related stenosis. Biomaterials, 2011, Volume: 32, Issue:14 Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Constriction, Pathologic; Deoxycytidine; Drug-Eluting Stents; Gastrointestinal Neoplasms; Gemcitabine; Male; Mice; Mice, Inbred BALB C; Polysaccharides; Polytetrafluoroethylene	2011
[A resected case of gastric regional lymph node metastasis from ascending colon cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:3 Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Colon, Ascending; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Staging; Remission Induction; Stomach Neoplasms	2011
Retinal vein thrombosis in a patient with metastatic colon cancer receiving XELOX chemotherapy combined with bevacizumab pre-hepatic resection. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2012, Volume: 18, Issue:1 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Oxaloacetates; Retinal Vein Occlusion; Risk Factors; Vision Disorders	2012
Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice. Cancer research, 2011, Aug-01, Volume: 71, Issue:15 Topics: Adenocarcinoma; Animals; CD11b Antigen; Coculture Techniques; Colonic Neoplasms; Deoxycytidine; Female; Gemcitabine; Interferon gamma Receptor; Interferon Type I; Interferon-gamma; Interferons; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Knockout; Myeloid Cells; Neoplasm Proteins; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Phosphorylation; Protein Processing, Post-Translational; Receptors, Cell Surface; Receptors, Interferon; Recombinant Proteins; Spleen; STAT1 Transcription Factor; Tumor Escape	2011
Resolving actinic keratoses: an expected side-effect of capecitabine therapy. Clinical and experimental dermatology, 2012, Volume: 37, Issue:1 Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Facial Dermatoses; Fluorouracil; Humans; Keratosis, Actinic; Male	2012
Recommendations and expert opinion on the adjuvant treatment of colon cancer in Spain. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2011, Volume: 13, Issue:11 Topics: Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Practice Guidelines as Topic; Spain	2011
Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands. Acta oncologica (Stockholm, Sweden), 2012, Volume: 51, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cohort Studies; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Guideline Adherence; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Netherlands; Organoplatinum Compounds; Oxaliplatin; Practice Guidelines as Topic; Registries; Treatment Outcome; Young Adult	2012
Targeting quiescent tumor cells via oxygen and IGF-I supplementation. Cancer research, 2012, Feb-01, Volume: 72, Issue:3 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Culture Techniques; Cell Hypoxia; Cell Proliferation; Cell Survival; Colonic Neoplasms; Deoxycytidine; Drug Synergism; Gemcitabine; HCT116 Cells; HT29 Cells; Humans; Insulin; Insulin-Like Growth Factor I; Mice; Mice, Inbred NOD; Mice, SCID; Oxygen; Paclitaxel; Receptor, IGF Type 1; Xenograft Model Antitumor Assays	2012
Initial report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japanese patients. International journal of clinical oncology, 2013, Volume: 18, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Drug-Related Side Effects and Adverse Reactions; Female; Fluorouracil; Hand-Foot Syndrome; Humans; Japan; Male; Middle Aged; Neoplasm Staging; Prospective Studies	2013
Gemcitabine-releasing polymeric films for covered self-expandable metallic stent in treatment of gastrointestinal cancer. International journal of pharmaceutics, 2012, May-10, Volume: 427, Issue:2 Topics: Alloys; Animals; Antimetabolites, Antineoplastic; Cell Count; Cell Proliferation; Cell Survival; Colonic Neoplasms; Constriction, Pathologic; Cytokines; Deoxycytidine; Drug-Eluting Stents; Gastrointestinal Neoplasms; Gemcitabine; Humans; Membranes, Artificial; Mice; p38 Mitogen-Activated Protein Kinases; Poloxamer; Polymers; Polytetrafluoroethylene; Polyurethanes	2012
[Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: a new case report]. Annales de dermatologie et de venereologie, 2012, Volume: 139, Issue:3 Topics: Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Follow-Up Studies; Hand-Foot Syndrome; Humans; Hyperpigmentation; Male; Remission, Spontaneous	2012
[Oral capecitabine as postoperative adjuvant chemotherapy in stage III colon cancer patients]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:3 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Hand-Foot Syndrome; Humans; Male; Middle Aged; Neoplasm Staging	2012
A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin. Clinical and experimental nephrology, 2012, Volume: 16, Issue:3 Topics: Acute Kidney Injury; Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Leucovorin; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prednisone; Thrombocytopenia	2012
ErbB3 expression predicts sensitivity to elisidepsin treatment: in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines. International journal of oncology, 2012, Volume: 41, Issue:1 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cisplatin; Colonic Neoplasms; Deoxycytidine; Depsipeptides; Drug Screening Assays, Antitumor; Drug Synergism; ErbB Receptors; Female; Gemcitabine; Humans; Inhibitory Concentration 50; Lung Neoplasms; Mitogen-Activated Protein Kinases; Paclitaxel; Receptor, ErbB-2; Receptor, ErbB-3; Receptor, ErbB-4	2012
Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies. Cell research, 2012, Volume: 22, Issue:8 Topics: Alleles; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Colonic Neoplasms; Deoxycytidine; DNA Topoisomerases, Type I; GATA2 Transcription Factor; Gemcitabine; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Mutation; Nuclear Proteins; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Pyrazines; ras Proteins; RNA Interference; RNA, Small Interfering; Topoisomerase I Inhibitors; Topotecan; Transcriptional Activation	2012
SL-01, an oral gemcitabine derivative, inhibited human cancer growth more potently than gemcitabine. Toxicology and applied pharmacology, 2012, Aug-01, Volume: 262, Issue:3 Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Line, Tumor; Colonic Neoplasms; Deoxycytidine; Enzyme Activation; Female; Gemcitabine; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation	2012
Antitumor effects of FP3 in combination with capecitabine on PDTT xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases. Cancer biology & therapy, 2012, Volume: 13, Issue:9 Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Capecitabine; Carcinoma; Colonic Neoplasms; Deoxycytidine; Drug Synergism; Female; Fluorouracil; Humans; Liver Neoplasms; Lymphatic Metastasis; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Neovascularization, Pathologic; Proliferating Cell Nuclear Antigen; Radiography; Recombinant Fusion Proteins; Thymidine Phosphorylase; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2012
Synthesis and biological evaluation of oral prodrugs based on the structure of gemcitabine. Chemical biology & drug design, 2012, Volume: 80, Issue:3 Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Biological Availability; Carcinoma, Hepatocellular; Cell Line, Tumor; Colonic Neoplasms; Deoxycytidine; Gemcitabine; Humans; Liver Neoplasms; Mice; Neoplasms; Prodrugs	2012
Colon carcinoma in a child treated with oxaliplatin and antiangiogenic treatment regimens. Pediatric hematology and oncology, 2012, Volume: 29, Issue:6 Topics: Adenocarcinoma; Adolescent; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fatal Outcome; Female; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds; Oxaliplatin	2012
Decrease in blood miR-296 predicts chemotherapy resistance and poor clinical outcome in patients receiving systemic chemotherapy for metastatic colon cancer. International journal of colorectal disease, 2013, Volume: 28, Issue:6 Topics: Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease Progression; Drug Resistance, Neoplasm; Fluorouracil; Humans; Indoles; MicroRNAs; Neoplasm Metastasis; Pyrroles; Sunitinib; Treatment Outcome	2013
[Therapy traces on hands and feet in a patient with colon cancer]. MMW Fortschritte der Medizin, 2012, Jun-21, Volume: O 154 Suppl 2 Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diagnosis, Differential; Fluorouracil; Hand-Foot Syndrome; Humans; Liver Neoplasms; Male; Palliative Care	2012
Occurrence of Sjögren syndrome in a long-term survivor patient with metastatic colon carcinoma treated with GOLFIG regimen. Journal of chemotherapy (Florence, Italy), 2012, Volume: 24, Issue:4 Topics: Adjuvants, Immunologic; Administration, Metronomic; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Injections, Subcutaneous; Interleukin-2; Leucovorin; Lung Neoplasms; Lymphatic Metastasis; Maintenance Chemotherapy; Organoplatinum Compounds; Remission Induction; Sjogren's Syndrome; Treatment Outcome	2012
Bevacizumab-containing chemotherapy is safe in patients with unresectable metastatic colorectal cancer and a synchronous asymptomatic primary tumor. Japanese journal of clinical oncology, 2013, Volume: 43, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Organoplatinum Compounds; Oxaliplatin; Prognosis; Rectal Neoplasms; Retrospective Studies; Survival Rate; Young Adult	2013
[Resolution of actinic keratosis with capecetabin]. Annales de dermatologie et de venereologie, 2012, Volume: 139, Issue:11 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Keratosis, Actinic; Male; Neoplasms, Radiation-Induced; Precancerous Conditions; Skin Neoplasms	2012
Hypertriglyceridaemia-induced pancreatitis: a contributory role of capecitabine? Hong Kong medical journal = Xianggang yi xue za zhi, 2012, Volume: 18, Issue:6 Topics: Administration, Oral; Adult; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Hand-Foot Syndrome; Humans; Hypertriglyceridemia; Pancreatitis, Acute Necrotizing; Triglycerides	2012
Solitary bulky mediastinal lymph node metastasis from colon cancer. Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2013, Volume: 19, Issue:4 Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Cell Differentiation; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Positron-Emission Tomography; Reoperation; Thoracic Surgery, Video-Assisted; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2013
[A case of transverse colon cancer with multiple liver metastases and hepatic pedicle lymph node involvement showing pathological complete response by XELOX plus bevacizumab]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:13 Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colon, Transverse; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Humans; Liver Neoplasms; Lymphatic Metastasis; Oxaloacetates	2012
[A case of simultaneous resection of pancreatic tail and transverse hematogenous metastasis]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:12 Topics: Antimetabolites, Antineoplastic; Colonic Neoplasms; Deoxycytidine; Fatal Outcome; Gemcitabine; Humans; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms	2012
[Assessment of hand-foot syndrome in cancer outpatients undergoing chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39 Suppl 1 Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Hand-Foot Syndrome; Humans; Outpatients; Quality of Life	2012
Unsupported off-label chemotherapy in metastatic colon cancer. BMC health services research, 2012, Dec-29, Volume: 12 Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Capecitabine; Cetuximab; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Insurance Claim Review; Middle Aged; Off-Label Use; Panitumumab; Practice Patterns, Physicians'; Retrospective Studies; United States	2012
Preliminary outcome of a treatment strategy based on perioperative chemotherapy and surgery in patients with locally advanced colon cancer. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2013, Volume: 15, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Length of Stay; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Operative Time; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Survival Rate; Tomography, X-Ray Computed	2013
Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies. Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:3 Topics: Breast Neoplasms; Colonic Neoplasms; Colony-Forming Units Assay; Colorimetry; Combined Modality Therapy; Deoxycytidine; Fluorescent Dyes; Gemcitabine; Humans; Lung Neoplasms; Radiation-Sensitizing Agents; Radiotherapy; Rhodamines; Sensitivity and Specificity; Tumor Cells, Cultured	2003
High-resolution magnetic resonance imaging of the efficacy of the cytosine analogue 1-[2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl]-N(4)-palmitoyl cytosine (CS-682) in a liver-metastasis athymic nude mouse model. Cancer research, 2003, May-15, Volume: 63, Issue:10 Topics: Animals; Antineoplastic Agents; Arabinonucleosides; Cell Division; Colonic Neoplasms; Cytosine; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Mice; Mice, Nude; Xenograft Model Antitumor Assays	2003
NICE recommends new treatment for breast and bowel cancer. BMJ (Clinical research ed.), 2003, May-31, Volume: 326, Issue:7400 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Docetaxel; Female; Fluorouracil; Humans; Paclitaxel; Practice Guidelines as Topic; Taxoids; Tegafur; Uracil	2003
Phenytoin toxicity due to fluoropyrimidines (5FU/capecitabine): three case reports. British journal of cancer, 2003, Aug-18, Volume: 89, Issue:4 Topics: Adenocarcinoma; Administration, Oral; Aged; Anticonvulsants; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Interactions; Epilepsy, Generalized; Female; Fluorouracil; Humans; Male; Middle Aged; Phenytoin	2003
Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Sep-01, Volume: 9, Issue:10 Pt 1 Topics: Animals; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Bromodeoxyuridine; Cell Cycle; Colonic Neoplasms; Deoxycytidine; Female; Gemcitabine; Humans; Ligands; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Genetic; Neoplasm Transplantation; Radioimmunotherapy; Recombinant Fusion Proteins; Time Factors; Tissue Distribution	2003
Rapid in vitro chemosensitivity analysis of human colon tumor cell lines. Toxicology and applied pharmacology, 2003, Nov-01, Volume: 192, Issue:3 Topics: Antineoplastic Agents; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; Cisplatin; Colonic Neoplasms; Culture Media; Deoxycytidine; Drug Screening Assays, Antitumor; Flow Cytometry; Gemcitabine; Humans; Hydrogen-Ion Concentration; Organoplatinum Compounds; Oxaliplatin; Reproducibility of Results; Tetrazolium Salts	2003
Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts: in vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Mar-01, Volume: 10, Issue:5 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Carboplatin; Colonic Neoplasms; Deoxycytidine; Dexamethasone; Drug Synergism; Gemcitabine; Glioma; Half-Life; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasms; Transplantation, Heterologous	2004
Chemoembolization of rat liver metastasis with microspheres and gemcitabine followed by evaluation of tumor cell load by chemiluminescence. Oncology reports, 2004, Volume: 11, Issue:5 Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Chemoembolization, Therapeutic; Colonic Neoplasms; Deoxycytidine; Disease Models, Animal; Fluorouracil; Gemcitabine; Liver Neoplasms; Male; Microspheres; Neoplasm Transplantation; Organ Size; Rats; Rats, Inbred Strains; Tumor Burden	2004
Effect of LY293111 in combination with gemcitabine in colonic cancer. Cancer letters, 2004, Jul-08, Volume: 210, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Body Weight; Colonic Neoplasms; Deoxycytidine; Gemcitabine; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Receptors, Leukotriene B4; Transplantation, Heterologous; Tumor Cells, Cultured	2004
Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabine. International journal of colorectal disease, 2004, Volume: 19, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Fluorouracil; Humans; Irinotecan; Male; Middle Aged; Treatment Outcome	2004
Positive interactive radiosensitisation in vitro with the combination of two nucleoside analogues, (E)-2'-deoxy-2'-(fluoromethylene) cytidine and iododeoxyuridine. European journal of cancer (Oxford, England : 1990), 2004, Volume: 40, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Colonic Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Drug Interactions; Humans; Idoxuridine; Radiation-Sensitizing Agents	2004
Severe disabling sensory-motor polyneuropathy during oxaliplatin-based chemotherapy. Anti-cancer drugs, 2004, Volume: 15, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disabled Persons; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Polyneuropathies; Severity of Illness Index	2004
Anti-metastatic effect of capecitabine on human colon cancer xenografts in nude mouse rectum. International journal of cancer, 2004, Oct-20, Volume: 112, Issue:1 Topics: Animals; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Gastrointestinal Neoplasms; Green Fluorescent Proteins; Humans; Luminescent Proteins; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Rectal Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Thymidine Phosphorylase; Transplantation, Heterologous	2004
Colon cancer with isolated metastasis to the kidney at the time of initial diagnosis. International journal of gastrointestinal cancer, 2003, Volume: 34, Issue:2-3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Kidney Neoplasms; Leucovorin; Male; Neoplastic Cells, Circulating; Nephrectomy	2003
[Adjuvant therapy of colonic carcinoma--soon in tablet form]. Krankenpflege Journal, 2004, Volume: 42, Issue:5-6 Topics: Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Fluorouracil; Humans; Multicenter Studies as Topic; Prodrugs; Randomized Controlled Trials as Topic; Tablets; Treatment Outcome	2004
Synergistic antitumor activity of capecitabine in combination with irinotecan. Clinical colorectal cancer, 2005, Volume: 4, Issue:5 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Cell Line, Tumor; Colonic Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Female; Fluorouracil; Irinotecan; Maximum Tolerated Dose; Mice; Mice, Nude; Neoplasm Transplantation; Quinazolines; Thiophenes	2005
Importance of preclinical investigations of the integration of capecitabine into polychemotherapy regimens. Clinical colorectal cancer, 2005, Volume: 4, Issue:5 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Cell Line, Tumor; Colonic Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Female; Fluorouracil; Irinotecan; Maximum Tolerated Dose; Mice; Mice, Nude; Neoplasm Transplantation; Quinazolines; Thiophenes	2005
Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:3 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Coronary Vasospasm; Deoxycytidine; Fluorouracil; Humans; Male; Middle Aged	2005
Adjuvant therapy for colon cancer--the pace quickens. The New England journal of medicine, 2005, Jun-30, Volume: 352, Issue:26 Topics: Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Fluorouracil; Humans; Neoplasm Staging	2005
Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response Journal of immunology (Baltimore, Md. : 1950), 2005, Jul-15, Volume: 175, Issue:2 Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Coculture Techniques; Colonic Neoplasms; Cross-Priming; Cytotoxicity, Immunologic; Dendritic Cells; Deoxycytidine; Drug Evaluation, Preclinical; Fluorouracil; Gemcitabine; HLA-A Antigens; HLA-A2 Antigen; HT29 Cells; Humans; Leucovorin; Leukocytes, Mononuclear; Organoplatinum Compounds; Oxaliplatin; T-Lymphocytes, Cytotoxic	2005
Streptokinase increases the sensitivity of colon cancer cells to chemotherapy by gemcitabine and cis-platine in vitro. Cancer letters, 2006, Jun-08, Volume: 237, Issue:1 Topics: Antineoplastic Agents; Cell Proliferation; Cisplatin; Colonic Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Fibrinolytic Agents; Gemcitabine; HT29 Cells; Humans; Streptokinase; Time Factors	2006
Capecitabine-warfarin interaction. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:9 Topics: Anticoagulants; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Interactions; Fluorouracil; Heart Valve Prosthesis Implantation; Humans; International Normalized Ratio; Male; Middle Aged; Mitral Valve; Warfarin	2005
Capecitabine as third line therapy in patients with advanced colorectal cancer. Acta oncologica (Stockholm, Sweden), 2005, Volume: 44, Issue:3 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Capecitabine; Carcinoembryonic Antigen; Colonic Neoplasms; Deoxycytidine; Disease Progression; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Irinotecan; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Prodrugs; Rectal Neoplasms; Retrospective Studies; Survival Rate	2005
Enhanced antitumor effect of the combination of tumstatin gene therapy and gemcitabine in murine models. Human gene therapy, 2005, Volume: 16, Issue:9 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autoantigens; Carcinoma, Lewis Lung; Cell Line, Tumor; Collagen Type IV; Colonic Neoplasms; Deoxycytidine; Disease Models, Animal; Endothelial Cells; Gemcitabine; Genetic Therapy; Genetic Vectors; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Plasmids; Recombinant Proteins; Treatment Outcome	2005
[Adjuvant therapy of colon cancer soon in tablet form]. Krankenpflege Journal, 2005, Volume: 43, Issue:4-6 Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Infusions, Intravenous; Neoplasm Staging	2005
Procainamide is a specific inhibitor of DNA methyltransferase 1. The Journal of biological chemistry, 2005, Dec-09, Volume: 280, Issue:49 Topics: Allosteric Regulation; Binding Sites; Binding, Competitive; Cell Line, Tumor; Chemoprevention; Colonic Neoplasms; CpG Islands; Deoxycytidine; DNA; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; DNA Methyltransferase 3B; Enzyme Activation; Enzyme Inhibitors; Gene Deletion; Humans; Procainamide; Recombinant Proteins; S-Adenosylmethionine; Substrate Specificity	2005
In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant. Cancer research, 2005, Oct-15, Volume: 65, Issue:20 Topics: Animals; Blotting, Western; Colonic Neoplasms; Cytidine Deaminase; Deoxycytidine; Deoxycytidine Kinase; Deoxycytosine Nucleotides; Drug Resistance, Neoplasm; Female; Gemcitabine; Gene Expression Profiling; Mice; Mice, Inbred BALB C; Nucleoside Deaminases; Oligonucleotide Array Sequence Analysis; Protein Subunits; Ribonucleotide Reductases	2005
Expression microarray analysis and oligo array comparative genomic hybridization of acquired gemcitabine resistance in mouse colon reveals selection for chromosomal aberrations. Cancer research, 2005, Nov-15, Volume: 65, Issue:22 Topics: Animals; Antimetabolites, Antineoplastic; Chromosome Aberrations; Colonic Neoplasms; Deoxycytidine; DNA Replication; Drug Resistance, Neoplasm; Gemcitabine; Gene Expression; Mice; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis	2005
Accrual delayed in adjuvant bevacizumab trial. Journal of the National Cancer Institute, 2006, Apr-05, Volume: 98, Issue:7 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Cause of Death; Chemotherapy, Adjuvant; Colonic Neoplasms; Controlled Clinical Trials as Topic; Deoxycytidine; Fluorouracil; Humans; Leucovorin; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin	2006
Acute coronary syndrome induced by capecitabine therapy. Heart, lung & circulation, 2006, Volume: 15, Issue:5 Topics: Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Coronary Angiography; Coronary Disease; Deoxycytidine; Diagnosis, Differential; Electrocardiography; Female; Fluorouracil; Humans; Middle Aged; Prodrugs	2006
Adjuvant chemotherapy of colon cancer: lymph node involvement without metastases. Prescrire international, 2006, Volume: 15, Issue:83 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Organoplatinum Compounds; Survival Rate; Treatment Outcome	2006
Hemoglobin induces colon cancer cell proliferation by release of reactive oxygen species. World journal of gastroenterology, 2006, Sep-21, Volume: 12, Issue:35 Topics: Antimetabolites, Antineoplastic; Capecitabine; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Fluorouracil; Gene Expression Regulation, Neoplastic; Hemoglobins; HT29 Cells; Humans; Oxidative Stress; Peroxidases; Peroxiredoxins; Reactive Oxygen Species; Superoxide Dismutase	2006
Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models. Cancer chemotherapy and pharmacology, 2007, Volume: 59, Issue:6 Topics: Animals; Cachexia; Capecitabine; Cell Line; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Hypercalcemia; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Parathyroid Hormone-Related Protein; Tumor Cells, Cultured; Weight Loss	2007
Tezacitabine enhances the DNA-directed effects of fluoropyrimidines in human colon cancer cells and tumor xenografts. Biochemical pharmacology, 2007, Jan-01, Volume: 73, Issue:1 Topics: Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Deoxycytidine; DNA; DNA Damage; Floxuridine; Fluorouracil; Humans; Thymidine Phosphorylase; Thymidylate Synthase; Transplantation, Heterologous	2007
Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment. Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:5 Suppl Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Erythema; Fluorouracil; Humans; Keratosis; Male; Paresthesia	2006
Combination therapy using gemcitabine and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin. Cancer biotherapy & radiopharmaceuticals, 2006, Volume: 21, Issue:5 Topics: Animals; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Carcinoembryonic Antigen; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Gemcitabine; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Peritoneal Neoplasms; Radiation-Sensitizing Agents; Radioimmunotherapy	2006
The Hollow Fibre Assay as a model for in vivo pharmacodynamics of fluoropyrimidines in colon cancer cells. British journal of cancer, 2007, Jan-15, Volume: 96, Issue:1 Topics: Administration, Oral; Animals; Apoptosis; Capecitabine; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; Deoxycytidine; Drug Combinations; Drug Synergism; Enzyme Inhibitors; Flow Cytometry; Floxuridine; Fluorouracil; Humans; Mice; Mice, Inbred BALB C; Pyrrolidines; Sensitivity and Specificity; Thymidine Phosphorylase; Thymine; Treatment Outcome; Trifluridine; Tumor Cells, Cultured; Uracil; Xenograft Model Antitumor Assays	2007
Toxicities and survival among octogenarians and nonagenarians with colorectal cancer treated with chemotherapy or concurrent chemoradiation therapy. Clinical colorectal cancer, 2007, Volume: 6, Issue:5 Topics: Age Factors; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Humans; Leucovorin; Male; Rectal Neoplasms; Retrospective Studies; Survival; Treatment Outcome	2007
Adjuvant therapy for stage II and III colorectal cancer. Seminars in oncology, 2007, Volume: 34, Issue:2 Suppl 1 Topics: Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Fluorouracil; Humans; Irinotecan; Leucovorin; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prodrugs; Rectal Neoplasms; Vitamin B Complex	2007
Etheno-DNA adduct formation in rats gavaged with linoleic acid, oleic acid and coconut oil is organ- and gender specific. Mutation research, 2007, Nov-01, Volume: 624, Issue:1-2 Topics: Animals; Cattle; Coconut Oil; Colon; Colonic Neoplasms; Deoxyadenosines; Deoxycytidine; DNA Adducts; Female; Humans; In Vitro Techniques; Leukocytes; Linoleic Acid; Lipid Peroxidation; Male; Oleic Acid; Organ Specificity; Plant Oils; Rats; Sex Characteristics	2007
Synergistic anti-tumor effect of recombinant chicken fibroblast growth factor receptor-1-mediated anti-angiogenesis and low-dose gemcitabine in a mouse colon adenocarcinoma model. World journal of gastroenterology, 2007, May-07, Volume: 13, Issue:17 Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Apoptosis; Cancer Vaccines; Cell Proliferation; Chickens; Colonic Neoplasms; Deoxycytidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Fibroblast Growth Factor 1; Gemcitabine; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Random Allocation; Recombinant Proteins; Survival Rate	2007
The impact of hypoxic treatment on the expression of phosphoglycerate kinase and the cytotoxicity of troxacitabine and gemcitabine. Molecular pharmacology, 2007, Volume: 72, Issue:3 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Colonic Neoplasms; Cytosine; Deoxycytidine; Dioxolanes; DNA-(Apurinic or Apyrimidinic Site) Lyase; Gemcitabine; Humans; Liver Neoplasms; Pancreatic Neoplasms; Phosphoglycerate Kinase; Rhabdomyosarcoma	2007
A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model. Cancer research, 2007, Aug-01, Volume: 67, Issue:15 Topics: Adenoviridae; Animals; Antigens, CD; Antigens, Differentiation; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Combined Modality Therapy; CTLA-4 Antigen; Cyclophosphamide; Dendritic Cells; Deoxycytidine; Docetaxel; Doxorubicin; Female; Flow Cytometry; Galactosylceramides; Gemcitabine; Genetic Vectors; Glucocorticoid-Induced TNFR-Related Protein; Humans; Immunization; Immunotherapy; Mice; Myeloid Cells; Peptide Fragments; Receptor, ErbB-2; Receptors, Nerve Growth Factor; Receptors, Tumor Necrosis Factor; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Taxoids; Transfection; Vaccines, DNA	2007
Regulation of DR-5 protein and mitochondrial transmembrane potential by gemcitabine, a possible mechanism of gemcitabine-enhanced TRAIL-induced apoptosis. Oncology reports, 2007, Volume: 18, Issue:3 Topics: Antimetabolites, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Deoxycytidine; DNA Fragmentation; Gastrointestinal Neoplasms; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Membrane Potentials; Mitochondrial Membranes; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand	2007
Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient. Journal of the European Academy of Dermatology and Venereology : JEADV, 2007, Volume: 21, Issue:10 Topics: Adenocarcinoma; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diagnosis, Differential; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Hyperpigmentation; Male; Vitiligo	2007
Comparative cytotoxicity of C-1311 in colon cancer in vitro and in vivo using the hollow fiber assay. Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:5 Topics: Aminoacridines; Animals; Antineoplastic Agents; Camptothecin; Capecitabine; Cell Line, Tumor; Cell Proliferation; Clinical Trials, Phase II as Topic; Colonic Neoplasms; Deoxycytidine; Drug Screening Assays, Antitumor; Fluorouracil; HT29 Cells; Humans; In Vitro Techniques; Irinotecan; Mice; Mice, Nude; Organoplatinum Compounds; Oxaliplatin; Paclitaxel	2007
Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activity. European journal of cancer (Oxford, England : 1990), 2008, Volume: 44, Issue:2 Topics: Analysis of Variance; Animals; Antimetabolites, Antineoplastic; Capecitabine; Cell Line, Tumor; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Gene Expression; Hepatocytes; Liver; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Heterologous	2008
Cost consequences of adjuvant capecitabine, Mayo Clinic and de Gramont regimens for stage III colon cancer in the French setting. Oncology, 2007, Volume: 72, Issue:3-4 Topics: Antineoplastic Agents; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Fluorouracil; France; Humans; Leucovorin; Treatment Outcome	2007
Capecitabine-related cardiotoxicity: recognition and management. The journal of supportive oncology, 2008, Volume: 6, Issue:1 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Heart Diseases; Humans; Incidence; Male; Middle Aged; Prodrugs; Rectal Neoplasms	2008
Polyaspartylhydrazide copolymer-based supramolecular vesicular aggregates as delivery devices for anticancer drugs. Biomacromolecules, 2008, Volume: 9, Issue:4 Topics: Antimetabolites, Antineoplastic; Apoptosis; Cells, Cultured; Chromatography, Gel; Chromatography, High Pressure Liquid; Colonic Neoplasms; Deoxycytidine; Drug Carriers; Drug Delivery Systems; Flow Cytometry; Gemcitabine; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Peptides; Polymers; Thyroid Neoplasms; Tumor Cells, Cultured	2008
Redefining adjuvant chemotherapy in patients with stage III colon cancer: X-ACT trial. Expert review of anticancer therapy, 2008, Volume: 8, Issue:4 Topics: Administration, Oral; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Costs and Cost Analysis; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Injections, Intravenous; Leucovorin; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Survival Rate	2008
Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts. Cancer letters, 2008, Aug-18, Volume: 267, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Combinations; Fluorouracil; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Oxonic Acid; Tegafur; Thrombospondin 1; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2008
Occurrence of autoimmunity in a long-term survivor with metastatic colon carcinoma treated with a new chemo-immunotherapy regimen. Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:2 Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Autoimmunity; Colonic Neoplasms; Deoxycytidine; Female; Flow Cytometry; Fluorouracil; Gemcitabine; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunotherapy; Interleukin-2; Leucovorin; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin	2008
Effect of thymidine on the toxicity, antitumor activity, and metabolism of 1-beta-D-arabinofuranosylcytosine in rats bearing a chemically induced colon carcinoma. Cancer research, 1980, Volume: 40, Issue:4 Topics: Animals; Arabinofuranosylcytosine Triphosphate; Biotransformation; Colonic Neoplasms; Cytarabine; Deoxycytidine; Drug Interactions; Drug Therapy, Combination; Female; Neoplasms, Experimental; Rats; Thymidine; Tissue Distribution	1980
Schedule-dependent antitumor effect of gemcitabine in in vivo model system. Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 11 Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma; Carcinoma, Squamous Cell; Colonic Neoplasms; Deoxycytidine; Drug Administration Schedule; Drug Screening Assays, Antitumor; Female; Gemcitabine; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Sarcoma; Soft Tissue Neoplasms	1995
Interaction between cisplatin and gemcitabine in vitro and in vivo. Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 11 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cisplatin; Colonic Neoplasms; Deoxycytidine; DNA Damage; DNA, Neoplasm; Drug Administration Schedule; Drug Resistance, Neoplasm; Drug Synergism; Drug Tolerance; Female; Fluorometry; Gemcitabine; Head and Neck Neoplasms; Humans; Injections, Intraperitoneal; Injections, Intravenous; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Tumor Cells, Cultured	1995
Synergistic interaction between cisplatin and gemcitabine in ovarian and colon cancer cell lines. Advances in experimental medicine and biology, 1994, Volume: 370 Topics: Animals; Antimetabolites, Antineoplastic; Cell Division; Cell Line; Cisplatin; Colonic Neoplasms; Cytidine Deaminase; Deoxycytidine; Deoxycytidine Kinase; Drug Screening Assays, Antitumor; Drug Synergism; Female; Gemcitabine; Humans; Kinetics; Mice; Nucleoside Deaminases; Ovarian Neoplasms; Time Factors; Tumor Cells, Cultured	1994
[Synergistic cytotoxic effects of chemotherapy in colon tumor cells by simultaneous inhibition of de novo and salvage energy metabolism pathways]. Wiener klinische Wochenschrift, 1994, Volume: 106, Issue:14 Topics: Allopurinol; Antimetabolites, Antineoplastic; Benzamidines; Cell Line; Cell Survival; Colonic Neoplasms; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Gemcitabine; Humans; Hypoxanthine; Hypoxanthines; Ribavirin; Ribonucleotide Reductases; Tumor Cells, Cultured; Tumor Stem Cell Assay	1994
Schedule dependence of sensitivity to 2',2'-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours. Biochemical pharmacology, 1994, Oct-07, Volume: 48, Issue:7 Topics: Animals; Antimetabolites, Antineoplastic; Cell Division; Colonic Neoplasms; Deoxycytidine; Drug Screening Assays, Antitumor; Female; Gemcitabine; Humans; Mice; Ovarian Neoplasms; Phosphates; Ribonucleotides; Tumor Cells, Cultured	1994
[Antitumor activity of LY 188011, a new deoxycytidine analog, against human cancers xenografted into nude mice]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:4 Topics: Animals; Antimetabolites, Antineoplastic; Body Weight; Colonic Neoplasms; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Neoplasm Transplantation; Stomach Neoplasms	1994
Antitumor activity of prolonged as compared with bolus administration of 2',2'-difluorodeoxycytidine in vivo against murine colon tumors. Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:4 Topics: Animals; Antimetabolites, Antineoplastic; Colonic Neoplasms; Deoxycytidine; Drug Administration Schedule; Drug Screening Assays, Antitumor; Gemcitabine; Infusions, Intravenous; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL	1996
Enhanced sensitivity to 1-beta-D-arabinofuranosylcytosine and topoisomerase II inhibitors in tumor cell lines harboring activated ras oncogenes. Cancer research, 1996, Nov-15, Volume: 56, Issue:22 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Cytarabine; Daunorubicin; Deoxycytidine; DNA Mutational Analysis; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gemcitabine; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Lung Neoplasms; Software; Topoisomerase II Inhibitors; Tumor Cells, Cultured	1996
Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft models. Investigational new drugs, 1996, Volume: 14, Issue:3 Topics: Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Colonic Neoplasms; Cytarabine; Deoxycytidine; Gemcitabine; Humans; Lung Neoplasms; Mice; Mice, Nude; Models, Biological; Molecular Structure; Pancreatic Neoplasms; Transplantation, Heterologous; Treatment Outcome	1996
Antitumor and radiosensitizing effects of (E)-2'-deoxy-2'-(fluoromethylene) cytidine, a novel inhibitor of ribonucleoside diphosphate reductase, on human colon carcinoma xenografts in nude mice. Cancer research, 1997, Sep-15, Volume: 57, Issue:18 Topics: Animals; Antineoplastic Agents; Carcinoma; Colonic Neoplasms; Deoxycytidine; Humans; Injections, Intraperitoneal; Injections, Intravenous; Leukocyte Count; Liver Neoplasms; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Radiation-Sensitizing Agents; Ribonucleotide Reductases; Survival Analysis; Transplantation, Heterologous	1997
Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts. Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:4 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Docetaxel; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Induction; Female; Fluorouracil; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Taxoids; Thymidine Phosphorylase; Transplantation, Heterologous; Tumor Necrosis Factor-alpha; Up-Regulation	1998
Induction of in vivo resistance against gemcitabine (dFdC, 2',2'-difluoro-deoxycytidine). Advances in experimental medicine and biology, 1998, Volume: 431 Topics: Animals; Antimetabolites, Antineoplastic; Cell Line; Colonic Neoplasms; Deoxycytidine; Deoxycytidine Kinase; Drug Resistance, Neoplasm; Gemcitabine; Kinetics; Mice; Mice, Inbred BALB C; Thymidine Kinase; Tumor Cells, Cultured	1998
Colon cancer: new drug options improve on 5-FU. Journal of the National Cancer Institute, 1998, Jul-01, Volume: 90, Issue:13 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Resistance, Neoplasm; Drug Synergism; Fluorouracil; Folic Acid Antagonists; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Quinazolines; Survival Analysis; Tegafur; Thiophenes; Thymidylate Synthase; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome	1998
Postconfluent multilayered cell line cultures for selective screening of gemcitabine. European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:6 Topics: Antimetabolites, Antineoplastic; Colonic Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gemcitabine; Humans; Nucleotides; Ovarian Neoplasms; Tumor Cells, Cultured	1998
Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2',2'-difluoro-2'-deoxycytidine (Gemcitabine). Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:5 Topics: Antimetabolites, Antineoplastic; Cell Survival; Cobalt Radioisotopes; Colonic Neoplasms; Deoxycytidine; DNA Damage; DNA Fragmentation; DNA, Neoplasm; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Electrophoresis, Gel, Pulsed-Field; Gemcitabine; Humans; Radiation-Sensitizing Agents; Tumor Cells, Cultured	1997
Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2'-deoxyuridine in HT-29 colon cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:11 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Colonic Neoplasms; Deoxycytidine; DNA Damage; DNA Fragmentation; DNA, Neoplasm; Floxuridine; Gemcitabine; HT29 Cells; Humans; Thymidylate Synthase	1998
Potentiation of cytotoxicity and radiosensitization of (E)-2-deoxy-2'-(fluoromethylene) cytidine by pentoxifylline in vitro. International journal of cancer, 1999, Jan-05, Volume: 80, Issue:1 Topics: Antineoplastic Agents; Cell Cycle; Cell Survival; Cesium Radioisotopes; Colonic Neoplasms; Deoxycytidine; DNA Damage; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; G2 Phase; Humans; Pentoxifylline; Radiation-Sensitizing Agents; S Phase; Tumor Cells, Cultured	1999
Positive results achieved with new oral chemotherapy agent. Oncology nursing forum, 1999, Volume: 26, Issue:4 Topics: Administration, Oral; Antineoplastic Agents; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged; Oncology Nursing	1999
Supraadditive effect of 2',2'-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines. Cancer chemotherapy and pharmacology, 1999, Volume: 44, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Deoxycytidine; DNA; Gemcitabine; Humans; Leukemia; Organoplatinum Compounds; Oxaliplatin; Tumor Cells, Cultured	1999
Cell cycle modulation by a multitargeted antifolate, LY231514, increases the cytotoxicity and antitumor activity of gemcitabine in HT29 colon carcinoma. Cancer research, 1999, Aug-01, Volume: 59, Issue:15 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Death; Cell Division; Colonic Neoplasms; Deoxycytidine; DNA Replication; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Folic Acid Antagonists; Gemcitabine; Glutamates; Guanine; HT29 Cells; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Pemetrexed	1999
Comparison of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine with gemcitabine in its antitumor activity. Cancer letters, 1999, Oct-01, Volume: 144, Issue:2 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Colonic Neoplasms; Cytarabine; Deoxycytidine; Drug Screening Assays, Antitumor; Female; Gemcitabine; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Stomach Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured	1999
Interaction between gemcitabine and mitomycin-C in vitro. Cancer chemotherapy and pharmacology, 2000, Volume: 45, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Deoxycytidine; Drug Synergism; Gemcitabine; Humans; Mitomycin; Tumor Cells, Cultured	2000
Expression of ERCC1 antisense RNA abrogates gemicitabine-mediated cytotoxic synergism with cisplatin in human colon tumor cells defective in mismatch repair but proficient in nucleotide excision repair. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:3 Topics: Antineoplastic Agents; Base Pair Mismatch; Cell Survival; Cisplatin; Colonic Neoplasms; Deoxycytidine; Deoxycytosine Nucleotides; DNA; DNA Repair; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Endonucleases; Gemcitabine; Gene Expression; Humans; Mutation; Proteins; RNA, Antisense; Tumor Cells, Cultured	2000
Tumor biology: use of tiled images in conjunction with measurements of cellular proliferation and death in response to drug treatments. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:8 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Division; Colonic Neoplasms; Cyclophosphamide; Deoxycytidine; Female; Gemcitabine; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Mice; Mice, Nude; Mitomycin; Neoplasms, Experimental; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2000
The role of apoptosis in 2',2'-difluoro-2'-deoxycytidine (gemcitabine)-mediated radiosensitization. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:2 Topics: Apoptosis; Caspase 3; Caspase Inhibitors; Caspases; Cell Survival; Cobalt Radioisotopes; Colonic Neoplasms; Coumarins; Deoxycytidine; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Radiation; Electrophoresis, Gel, Pulsed-Field; Enzyme Activation; Gemcitabine; Head and Neck Neoplasms; Humans; Lung Neoplasms; Oligopeptides; Radiation-Sensitizing Agents; Tumor Cells, Cultured	2001
5-fluorouracil/leucovorin versus capecitabine in patients with stage III colon cancer. Seminars in oncology, 2001, Volume: 28, Issue:1 Suppl 1 Topics: Administration, Oral; Antineoplastic Agents; Capecitabine; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colonic Neoplasms; Deoxycytidine; Drug Therapy, Combination; Fluorouracil; Humans; Leucovorin; Multicenter Studies as Topic; Neoplasm Staging; Randomized Controlled Trials as Topic	2001
Investigation of 5-FU disposition after oral administration of capecitabine, a triple-prodrug of 5-FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: comparison of the simulated 5-FU exposures in the tumour tissue b Biopharmaceutics & drug disposition, 2001, Volume: 22, Issue:1 Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Area Under Curve; Capecitabine; Colonic Neoplasms; Cytosol; Deoxycytidine; Dose-Response Relationship, Drug; Fluorouracil; Humans; Kidney; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Prodrugs; Subcellular Fractions; Therapeutic Equivalency; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2001
In Vitro schedule-dependent interactions between the multitargeted antifolate LY231514 and gemcitabine in human colon adenocarcinoma cell lines. Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:1 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Apoptosis; Colonic Neoplasms; Deoxycytidine; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Resistance, Neoplasm; Drug Therapy, Combination; Flow Cytometry; Folic Acid Antagonists; Gemcitabine; Glutamates; Guanine; Humans; In Situ Nick-End Labeling; Pemetrexed; Thymidylate Synthase; Tumor Cells, Cultured	2002
Concentration and time dependent growth inhibition and metabolism in vitro by 2',2'-difluoro-deoxycytidine (gemcitabine). Advances in experimental medicine and biology, 1991, Volume: 309A Topics: Animals; Antimetabolites, Antineoplastic; Biotransformation; Carcinoma, Squamous Cell; Cell Division; Cell Line; Colonic Neoplasms; Deoxycytidine; Drug Screening Assays, Antitumor; Female; Gemcitabine; Head and Neck Neoplasms; Humans; Kinetics; Mice; Ovarian Neoplasms	1991
Arabinosyl-5-azacytosine: mechanisms of native and acquired resistance. Cancer research, 1986, Volume: 46, Issue:9 Topics: Animals; Azacitidine; Biological Transport; Colonic Neoplasms; Cytidine; Deoxycytidine; Deoxycytidine Kinase; DNA; Drug Resistance; Humans; Leukemia P388; Mice; Phosphorylation	1986